WO2014162439A1 - Syringe - Google Patents

Syringe Download PDF

Info

Publication number
WO2014162439A1
WO2014162439A1 PCT/JP2013/059911 JP2013059911W WO2014162439A1 WO 2014162439 A1 WO2014162439 A1 WO 2014162439A1 JP 2013059911 W JP2013059911 W JP 2013059911W WO 2014162439 A1 WO2014162439 A1 WO 2014162439A1
Authority
WO
WIPO (PCT)
Prior art keywords
cylinder
magnet
gasket
syringe
locking
Prior art date
Application number
PCT/JP2013/059911
Other languages
French (fr)
Japanese (ja)
Inventor
亜莉紗 山下
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to PCT/JP2013/059911 priority Critical patent/WO2014162439A1/en
Publication of WO2014162439A1 publication Critical patent/WO2014162439A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/20Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/002Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3202Devices for protection of the needle before use, e.g. caps

Definitions

  • the present invention relates to a syringe in which a gasket slides by magnetic repulsion without having a plunger.
  • the syringe is used when injecting a drug solution into a patient or the like.
  • the syringe has a cylinder having an injection needle attached to the distal end and an opening at the proximal end, and a gasket that is inserted into and slides there.
  • a plunger is attached to the gasket. When the plunger protruding from the opening of the syringe is pushed, the gasket slides, and the medicine previously stored in the cylinder can be discharged and injected.
  • This plunger needs to have a length equal to or longer than that of the cylinder so that the gasket can reach the end of the cylinder in order to reliably discharge the chemical solution.
  • Syringes are used not only by medical doctors and nurses in medical practice, but also when self-injecting medicinal solutions by diabetics and rheumatic patients.
  • prefilled syringes are prestored in a cylinder in order to prevent contamination of the bacteria of the chemical and simplify the preparation of the chemical.
  • Patent Document 1 one end of an ampoule containing a drug suspension is closed with a piston, a metal-containing fixing member is provided on the piston, and a magnetic member such as a bead in the suspension is attracted magnetically, and shaken manually. An administration device is then disclosed in which the mixing member is released to diffuse the suspension.
  • syringes and administration devices require a plunger to slide the gasket in the cylinder.
  • the conventional syringe is long due to the plunger.
  • a flange at the base end of the cylinder to which a finger is applied when the plunger is pushed has to be provided, and the entire width of the syringe is large by this flange.
  • Such a syringe requires an operation of pressing the proximal end of the plunger with the thumb and pushing it into the cylinder with force while placing the index finger and the middle finger on the front end of the flange during injection.
  • needles used for self-injection have been devised to reduce the tip of the needle in order to reduce pain during injection.
  • a liquid medicine may be injected with a small-diameter injection needle into the upper layer of the skin such as the epidermis or dermis where many immunocompetent cells are present so that the injection amount of a biologic such as a vaccine may be small.
  • the syringe When a syringe is used for self-injection, it is desired that the syringe be small and light so that the patient can inject it in a timely manner, and can be easily injected with little force even when high injection input is required, and easy to carry.
  • the present invention has been made to solve the above-described problems, and an object of the present invention is to provide a syringe that does not have a plunger, is small and excellent in portability, and can discharge a chemical solution with a simple operation.
  • the syringe of the present invention which has been made to achieve the above object, includes a cylinder having a cylinder tip at the tip and an opening at the base, a gasket that is inserted into the cylinder and slides by pressing, and the cylinder A syringe that is contained between the cylinder tip and the gasket and is discharged from the cylinder tip by sliding of the gasket, and is fixed to the cylinder and an in-cylinder magnet inserted into the cylinder.
  • a counter magnet that surrounds the cylinder and generates a bias with a magnetic repulsive force generated by causing the same magnetic pole to face the in-cylinder magnet to induce the sliding of the gasket to the tip portion.
  • at least one of the in-cylinder magnet and the counter magnet is locked to the cylinder, and the bias is accumulated until the locking is released, or the locking is released and then the locking is released.
  • the syringe generates the bias by pressing the in-cylinder magnet and the counter magnet against the magnetic repulsive force while facing each other with the same magnetic poles, and the stopper includes the in-cylinder magnet. It is preferable that the urging force is accumulated by locking.
  • the in-cylinder magnet is embedded in an in-cylinder holder having a fitting portion on a side surface, and the stopper is fitted in the fitting portion, thereby locking the in-cylinder magnet. Also good.
  • the fitting portion is recessed in the circumferential direction of the in-cylinder holder, and a groove for locking the in-cylinder holder together with the in-cylinder magnet is depressed in the central axis direction of the in-cylinder holder. It is preferable that the groove to be released is connected.
  • the syringe may be provided with a hook for releasing the locking by removing the fitting between the stopper and the fitting portion from the outside of the cylinder.
  • the in-cylinder magnet and the annular counter magnet that surrounds the cylinder together with the in-cylinder magnet are magnetized in the circumferential direction of the respective side surfaces, and magnetic attractive force is generated by opposing the different magnetic poles.
  • the urging is generated after the stopper is released by stopping the counter magnet in a non-rotatable manner.
  • the in-cylinder magnet and the counter magnet may be radial anisotropic magnets.
  • the in-cylinder magnet may be embedded in an in-cylinder holder.
  • the syringe liquid discharge method includes: a cylinder tip at the tip, and a cylinder provided with an opening at the base end; a gasket that is inserted into the cylinder and slides by pressing; and the cylinder tip and the gasket in the cylinder
  • the biasing is accumulated until the locking is released, or the step of generating the biasing after the locking is released, the biasing is performed by the in-cylinder magnet according to the release of the locking.
  • the in-cylinder magnet is urged by the magnetic repulsion between the opposing magnet fixed to the cylinder or surrounding the in-cylinder magnet and the in-cylinder magnet inserted in the cylinder, Since it is slid, a plunger inserted into the cylinder and a flange protruding at the base end of the cylinder are not required. Therefore, since the syringe can be shortened and made small, it is particularly convenient for a patient who performs self-injection to carry.
  • the syringe Even if the syringe is a handicapped patient or an elderly person with weak finger strength, the syringe that holds the in-cylinder magnet or the opposing magnet is pushed with a slight force or a finger is applied.
  • the drug solution can be easily discharged and injected simply by pulling or picking and rotating. In addition, it is possible to simply inject at a medical site by a quick and simple operation without malfunction.
  • This syringe can stop the sliding of the gasket by simply rotating the stopper, and discharge the medicine into small doses for each required dose for injection.
  • the discharge operation of the chemical solution can be easily performed with a simple operation.
  • FIG. 1 shows an embodiment of the syringe 10 of the present invention.
  • FIG. 1A is an exploded perspective view of the syringe 10
  • FIG. 1B is a perspective view showing a state in which the syringe 10 is assembled.
  • the syringe 10 includes a cylinder 30, an injection needle 22 joined to the cylinder tip 31, a fixed holder 47 fitted in the opening 34 of the cylinder 30, and a stopper 51 that surrounds a part of the side wall of the cylinder 30. ing.
  • the cylinder 30 is formed of a transparent material so that the inside can be visually confirmed.
  • the tube 30 is formed with a tube tip 31 having a reduced diameter at a distal end portion and an opening 34 provided at a proximal end portion.
  • a gasket 42 is inserted into the cylinder 30.
  • a chemical solution 41 is accommodated between the tube tip 31 and the gasket 42 in the tube 30.
  • the gasket 42 is in close contact with the inner wall surface of the cylinder 30 in an airtight manner, thereby preventing the chemical liquid 41 from leaking.
  • the gasket 42 is integrated with a substantially cylindrical in-cylinder holder 44 in which an in-cylinder magnet 43 is embedded.
  • the in-cylinder holder 44 and the inner wall surface of the cylinder 30 are hooked so as not to rotate.
  • a linear rotation piece 32 a parallel to the central axis of the cylinder 30 slightly protrudes from the inner wall surface of the cylinder 30.
  • the latching portion 44a that is recessed on the side surface of the in-cylinder holder 44 is provided in parallel with the central axis of the in-cylinder holder 44 and is hooked to the rotation piece 32a.
  • the rotation piece 32a and the latching portion 44a prevent the in-cylinder holder 44 from rotating as the stopper 51 rotates.
  • the rotation stop piece 32a forms a smooth arc so as not to damage the gasket 42.
  • the tube tip 31 has a diameter smaller than that of the body portion 32.
  • the injection needle 22 protrudes from the tip.
  • the injection needle 22 penetrates the tube tip 31 and communicates the inside and outside of the tube 30.
  • a cap 21 that is an elastic body is attached to the tube tip 31.
  • the cap 21 is pierced with an injection needle 22. Thereby, the cylinder 30 is sealed, and the chemical solution 41 in the cylinder 30 is prevented from leaking or being contaminated when the syringe 10 is transported or stored.
  • FIG. 2 (a) shows a partially cutaway partial perspective view of the syringe 10.
  • FIG. On the end face of the in-cylinder holder 44 on the gasket 42 side, a flange portion 44b having a T-shaped cross section protrudes. The flange portion 44b is inserted into a hole 42a formed in the end surface of the gasket 42 on the cylinder holder 44 side.
  • the gasket 42 is molded from an elastic material and is highly flexible. Thereby, the collar part 44b can be easily pushed into the hole 42a.
  • the in-cylinder holder 44 is inserted into the cylinder 30 together with the gasket 42.
  • the in-cylinder magnet 43 is a permanent magnet having magnetic poles at both end surfaces, and the surface on the distal end side of the cylinder 30 is an S pole and the surface on the proximal end side is an N pole.
  • the cylinder holder 44 has a fitting portion 45 on the side surface.
  • the fitting portion 45 is a groove in which a locking groove 45 a that is recessed in the circumferential direction of the in-cylinder holder 44 and a release groove 45 b that is recessed in the central axis direction of the in-cylinder holder 44 are connected at a substantially right angle.
  • Two fitting portions 45 are provided in line symmetry with the central axis of the in-cylinder holder 44 as the symmetry axis.
  • a locking groove 45a is exposed from the through hole 33 penetrating the side wall of the cylinder 30 (see FIG. 1B).
  • a fixed holder 47 in which a counter magnet 46 is embedded is fitted in the opening 34 and fixed by adhesion or heat welding.
  • the counter magnet 46 is a permanent magnet having magnetic poles at both end surfaces, and the surface on the distal end side of the cylinder 30 is an N pole and the surface on the proximal end side is an S pole.
  • the counter magnet 46 generates a magnetic repulsive force that generates a mutual repelling force by causing the in-cylinder magnet 43 and the N poles to face each other.
  • the in-cylinder magnet 43 is urged by being pressed against the opposing magnet 46 against this magnetic repulsion.
  • the stopper 51 has a semi-cylindrical shape. On the inner wall surface of the stopper 51, two locking projections 52 protrude in symmetrical positions. The locking projection 52 is fitted into the locking groove 45 a through the through hole 33. Thereby, the stopper 51 holds the in-cylinder magnet 43 and keeps the bias of the in-cylinder magnet 43 so that the gasket 42 is not pressed until the chemical solution 41 is discharged.
  • the stopper 51 can be rotated in the direction of the arrow shown in FIG.
  • the outer periphery of the stopper 51 is recessed so that it can be easily picked with a finger.
  • FIG. 2A shows a partially cutaway partial perspective view of the syringe 10 released from the locking by the stopper 51.
  • the in-cylinder magnet 43 presses and slides the gasket 42 together with the in-cylinder holder 44 toward the distal end portion of the cylinder 30 by the accumulated bias.
  • the drug solution 41 can be discharged from the injection needle 22 through the tube tip 31 by the sliding gasket 42.
  • the syringe 41 can discharge the chemical solution 41 contained in the cylinder 30. .
  • the overall length of the syringe 10 can be shortened compared to the case where a plunger is used.
  • the chemical solution 41 is not contaminated while being sealed, and the syringe 10 is safe.
  • the strength of the magnetic repulsion generated between the in-cylinder magnet 43 and the counter magnet 46 depends on the surface magnetic flux density of the magnet under the condition that the shape and surface area of the magnets are constant. The higher the surface magnetic flux density, the stronger the magnetic repulsion, and vice versa. For this reason, the surface magnetic flux density exerts an urging force on the in-cylinder magnet 43 and affects the force that presses and slides the gasket 42.
  • the surface magnetic flux density of the magnet is preferably from 100 to 30000 G, more preferably from 100 to 20000 G, and even more preferably from 1000 to 10000 G. If the surface magnetic flux density is smaller than this range, the magnetic repulsive force is insufficient, and the in-cylinder magnet 43 cannot be sufficiently biased, so that the gasket 42 cannot be pressed.
  • the magnet is a strong magnetic force, so that it becomes expensive and not economically practical, and there is a risk of causing malfunctions in peripheral medical devices due to the magnetism of the magnet.
  • the magnetic flux density of the magnet is appropriately set according to the outer diameter of the cylinder 30, the sliding resistance of the gasket 34, the viscosity of the drug solution 33, the inner diameter and length of the injection needle 21, the site to be injected, and the like.
  • a neodymium magnet, an alnico magnet, a samarium cobalt magnet, or a ferrite magnet can be given.
  • neodymium magnets have the advantage of large magnetic repulsion.
  • Alnico magnets have excellent mechanical strength and can be molded into any shape. Since the surface magnetic flux density hardly changes depending on the temperature, the samarium cobalt magnet can be used at any temperature.
  • the syringe 10 shown in FIG. 1 is manufactured as follows. First, the injection needle 22 is directly joined to the tube tip 31 while the tube 30 is formed by insert molding. The cap 21, which is an elastic body, is attached to the tube tip 31 by piercing the injection needle 22 straight, and the needle tip of the injection needle 22 is sealed. This is subjected to sterilization such as high-pressure steam sterilization. Next, a desired chemical solution 41 is filled into the cylinder 30. The flange portion 44b of the in-cylinder holder 44 is pushed into the hole 42a of the gasket 42 to integrate them.
  • the gasket 42 and the in-cylinder holder 44 are pushed into the cylinder 30 and the drug solution 41 is sealed while the rotation piece 32a is fitted in the latching portion 44a that is recessed on the side surface of the in-cylinder holder 44.
  • the material of the stopper 51 is somewhat more flexible than the material of the cylinder 30.
  • the stopper 51 is bent once and pushed open, and both locking projections 52 are fitted into the locking grooves 45 a through the through holes 33 of the cylinder 30. Then, the stopper 51 is restored by its own elasticity. Both the locking projections 52 are caught in the locking groove 45 a, and the in-cylinder holder 44 is locked together with the in-cylinder magnet 43.
  • a fixing holder 47 integrated with the counter magnet 46 is fitted from the opening 34, pushed in so as to oppose the magnetic repulsive force, and fixed by bonding or heat welding with an adhesive.
  • the syringe 10 is housed in a blister packaging material and sterilized as necessary.
  • the syringe 10 filled with the chemical solution 41 may be sterilized and then stored in the blister packaging material.
  • the syringe 10 is used as follows when the patient himself uses it for self-injection.
  • the doctor / nurse or the patient to be self-injected removes the mount of the blister packaging material, takes out the syringe 10, and removes the cap 21 fitted to the tube tip 31.
  • the body 10 is held and the syringe 10 is held.
  • the injection needle 22 is punctured, for example, subcutaneously at a site to be injected, such as the upper arm, abdomen, or thigh.
  • the stopper 51 is rotated in the direction of the arrow shown in FIG. 2A while fixing the syringe 10 so that the injection needle 22 does not come out of the site to be injected.
  • the locking projection 52 moves from the locking groove 45a to the release groove 45b to release the lock, slides on the release groove 45b, and finally comes out of the release groove 45b.
  • the in-cylinder magnet 43 is unlocked, and the in-cylinder magnet 43 presses the gasket 42 together with the in-cylinder holder 44 by urging by the magnetic repulsive force, and the gasket 42 slides toward the cylinder tip 31.
  • the drug solution 41 is discharged from the cylinder 30 through the injection needle 22 and injected into the patient's body.
  • the syringe 10 together with the injection needle 22 is removed from the body.
  • the syringe 10 is discarded as infectious medical waste.
  • the stopper 51 may be removed from the cylinder 30 and reused before the syringe 10 is discarded.
  • the chemical solution 41 may be in a cartridge-type refill form.
  • FIG. 1 and 2 show an example in which the in-cylinder holder 44 in which the in-cylinder magnet 43 is embedded and the gasket 42 are integrated. However, both are separated in an unused state, and the in-cylinder magnet 43 is It may be inserted between the gasket 42 and the opening 34 (not shown). In this case, when the in-cylinder holder 43 is released from being locked by the rotation of the stopper 51, the in-cylinder holder 44 abuts on the gasket 42 by this urging and presses the gasket 42. Slide. Thereby, the chemical liquid 41 is discharged.
  • a slit (not shown) that connects the through hole 33 and the periphery of the opening 34 may be provided on the side wall of the body portion 32.
  • the injection needle 22 may be joined to a needle base (not shown).
  • the needle 22 is connected to the inside and outside of the cylinder 30 by attaching the needle base to the cylinder tip 31.
  • FIG. 3 shows a perspective view of another embodiment of the syringe 10.
  • the fixed holder 47 has two claws 47a projecting symmetrically from the peripheral edge of the end of the tube tip.
  • the fixing holder 47 is fixed by adhesion or welding by being fitted into the opening 34 while the claw 47a is fitted in the release groove 45b.
  • the claw 47 a prevents the in-cylinder holder 44 from rotating as the stopper 51 rotates.
  • the release groove 45b has a function of preventing the in-cylinder holder 44 from rotating when the stopper 51 is rotated, and a function of moving the in-cylinder holder 44 by sliding the locking projection 52 when the stopper 51 is fully rotated. Have both. Therefore, the number of parts can be reduced.
  • FIG. 4 shows a perspective view of another embodiment of the syringe 10.
  • the syringe 10 can slide the gasket 42 in stages.
  • the syringe 10 is fixed to the cylinder 30, the gasket 42 inserted therein, the cylinder holder 44 in which the cylinder magnet 43 is embedded, and the opening magnet 34, and the counter magnet 46 is embedded.
  • a fixed holder 47 and a stopper 51 are provided.
  • the in-cylinder magnet 43 and the counter magnet 46 are opposed to each other with N poles.
  • the in-cylinder magnet 43 is urged by a magnetic repulsion generated between the magnets.
  • a fitting portion 45 is provided on the side surface of the in-cylinder holder 44.
  • the fitting portion 45 is a groove having locking grooves 45 a and 45 c that are recessed in the circumferential direction of the in-cylinder holder 44 and release grooves 45 b and 45 d that are recessed in the central axis direction of the in-cylinder holder 44.
  • Two fitting portions 45 are provided in line symmetry on the side surface of the in-cylinder holder 44.
  • the fitting portion 45 is connected to the gasket 42 from the side of the first locking groove 45a, the first release groove 45b, the second lock groove 45c, and the second release groove 45d in a substantially right angle. Yes.
  • the locking protrusion 52 locks the in-cylinder holder 44 together with the in-cylinder magnet 43 by being fitted in the first locking groove 45a.
  • the in-cylinder magnet 43 accumulates urging force by being pressed and locked against the magnetic repulsive force generated between the opposing magnet 46.
  • the stopper 51 rotates in the direction of the arrow, the locking projection 52 moves to a substantially right angle portion where the first locking groove 45a and the first release groove 45b are connected (FIG. 4B). .
  • the in-cylinder magnet 43 thus released from the lock presses the gasket 42 toward the cylinder tip 31 by the accumulated bias.
  • the locking projection 52 slides on the first release groove 45b, moves to a substantially right angle portion where the second locking groove 45c is connected, and comes into contact with the locking groove 45c (FIG. 4C). )). Thereby, the in-cylinder magnet 43 is locked again. Half of the amount of the chemical solution 41 initially contained in the cylinder 30 is discharged.
  • FIG. 4C the in-cylinder magnet 43 locked by the stopper 51 is separated from the opposing magnet 46 as compared with FIG. The magnet 43 is still accumulating bias due to magnetic repulsion.
  • the stopper 51 is rotated in the direction of the arrow shown in FIG. 4 (c)
  • the locking projection 52 is positioned at a substantially right angle portion where the second locking groove 45c and the second release groove 45d are connected.
  • Move (FIG. 4D) The locking projection 52 slides in the second release groove 45 b and does not fit into the fitting portion 45 through the proximal end of the in-cylinder holder 44.
  • the gasket 42 is pressed and slid by the in-cylinder magnet 43 and reaches the tip of the cylinder 30, the discharge of the chemical liquid 41 is completed (FIG. 4 (e)).
  • the syringe 10 can discharge
  • FIG. 5 shows another embodiment of the syringe 10.
  • FIG. 5A is a perspective view showing the manufacturing process of the syringe 10.
  • the stopper 51 has an arch shape, and the locking projection 52 and the support projection 53 protrude from the inner peripheral surface thereof.
  • the protrusions 52 and 53 protrude from the stopper 51 in correspondence with the through hole 33 opened in the cylinder 30 and the recessed portion 32b that is recessed.
  • the locking projection 52 is fitted into the fitting portion 45 through the through hole 33 to lock the in-cylinder holder 44.
  • the support protrusion 53 is fitted into a recessed portion 32 b that is recessed in a part of the outer wall of the body portion 32.
  • the stopper 51 is supported by the support protrusion 53 so that it does not fall off even when the locking protrusion 52 is removed.
  • One end of the stopper 51 on the side of the locking projection 52 is connected to a pressing hook 54 that has warped from an arch-shaped curve.
  • Anti-slip ribs are provided on the surface of the pressing hook 54. Since the stopper 51 is formed of a flexible material, it can be restored to its original shape even if it is slightly bent.
  • the stopper 51 is attached after the chemical solution 41, the gasket 42 and the in-cylinder holder 44 are inserted into the cylinder 30.
  • the support protrusion 53 is fitted into the recess 32b. With this fitting as a fulcrum, the locking projection 52 is fitted into the fitting portion 45 while the stopper 51 is expanded and bent.
  • the in-cylinder magnet 43 is locked by the stopper 51.
  • the fixing holder 47 in which the counter magnet 46 is embedded is fitted into the opening 34 and fixed by adhesion or heat welding, with the in-cylinder magnet 43 and the N poles facing each other.
  • the in-cylinder magnet 43 is urged by a magnetic repulsion generated between the counter magnet 46 and the urging force is accumulated by the locking by the stopper 51.
  • the patient punctures the skin with the injection needle 22, and then presses the pressing hook 54 in the direction of the arrow as shown in FIG.
  • the locking projection 52 is detached from the fitting portion 45 when the stopper 51 is bent with the fitting portion of the support projection 53 and the recess 32b as a fulcrum.
  • the in-cylinder magnet 43 is unlocked and presses the gasket 42 with the accumulated bias.
  • the stopper 51 returns to its original shape due to its flexibility.
  • the chemical liquid 41 is discharged by the gasket 42 that slides with the bias of the in-cylinder magnet 43.
  • the cylindrical holder 44 is provided with two symmetrical fitting portions 45 as the through holes 33 instead of the recesses 32b and as the locking projections 52 instead of the support projections 53, so that the in-cylinder holders are provided at a plurality of locations.
  • the in-cylinder magnet 43 may be locked together with 44.
  • the in-cylinder magnet 43 can be more reliably locked by fitting the locking protrusions 52 and the fitting portions 45 in a plurality.
  • FIG. 6 shows another embodiment of the syringe 10.
  • the stopper 51 has a pull-out hook 56 and a locking pin 55 connected on the outer periphery thereof.
  • the pull-out hook 56 has a ring shape so that it can be easily pulled by hooking a finger.
  • Two through holes 33 are formed symmetrically on the side wall of the cylinder 30.
  • the fitting portion 45 is a hole that penetrates the in-cylinder holder 44.
  • the locking pin 55 is fitted through the fitting portion 45 through the one through hole 33, and the tip of the locking pin 55 projects out of the cylinder 30 through the other through hole 33.
  • the tip of the locking pin 55 is slightly bent. When the force in the direction of the arrow is unexpectedly applied to the pulling hook 56, the bent tip prevents the locking pin 55 from being pulled out unexpectedly by being caught by the fitting portion 45.
  • the extraction hook 56 When the extraction hook 56 is pulled in the direction of the arrow during the discharge of the chemical solution 41, the tip of the locking pin 55 is bent and pulled into the fitting portion 45, and finally the stopper 51 comes off and comes off. As a result, the in-cylinder magnet 43 is unlocked, and presses and slides the gasket 42. The drug solution 41 is discharged from the injection needle 22 through the tube tip 31.
  • the pull-out hook 56 may be formed to have a large inner diameter or a hook shape so that several fingers can be hooked.
  • the stopper 51 has a pressing hook 54 and a pulling hook 56, the drug solution 41 can be discharged and injected simply by pushing or pulling the stopper. Therefore, even patients with rheumatism, such as patients with hand movement difficulties or weak grip, and elderly people can easily inject themselves without the assistance of their family members. The burden on the patient during self-injection can be reduced.
  • FIG. 7 shows a perspective view and a schematic perspective view of another embodiment of the syringe 10.
  • the syringe 10 has the cylinder 30 which accommodated the chemical
  • a gasket 42 and an in-cylinder holder 44 in which an in-cylinder magnet 43 is embedded are inserted into the cylinder 30.
  • a counter magnet 46 having an annular shape is embedded in the stopper 51 coaxially with the stopper 51. Both the in-cylinder magnet 43 and the counter magnet 46 are radial anisotropic magnets magnetized to four poles in the respective circumferential directions.
  • the collar portion 32c protrudes.
  • the stopper 51 is inserted into the cylinder 30 from the base end of the cylinder 30, and the end surface of the cylinder 30 on the distal end side is brought into contact with the flange portion 32c.
  • the stopper 51 can rotate coaxially with the cylinder 30.
  • the outer periphery of the stopper 51 is recessed in the middle so that it can be easily picked or pinched with fingers and rotated.
  • the opening 34 is closed with a lid 57 fitted.
  • the lid 57 has a shape in which the base end of the ring portion 57a fitted in the opening 34 is connected to the presser portion 57b having a larger diameter.
  • An air hole 57 c is opened at the center of the lid 57.
  • the air hole 57c is for introducing air into the cylinder 30 on the base end side of the gasket 42 when the gasket 42 slides toward the cylinder tip 31, so that the gasket 42 slides smoothly. is there.
  • the presser portion 57 b protrudes slightly from the side wall of the cylinder 30 and is in contact with the stopper 51. The stopper 51 does not fall out of the cylinder 30 by being sandwiched between the collar portion 32c and the pressing portion 57b.
  • the in-cylinder magnet 43 is restricted in rotation within the cylinder 30 by the hooking portion 44 a that is recessed on the side surface of the in-cylinder holder 44 and the locking piece 32 a that protrudes from the inner wall of the cylinder 30 being engaged with each other. Yes.
  • FIG. 7 (b) and 7 (c) are schematic perspective views showing the positions of the magnetic poles of the in-cylinder magnet 43 and the counter magnet 46.
  • FIG. 7B the counter magnet 46 surrounds the in-cylinder magnet 43 while the in-cylinder magnet 43 and the different magnetic poles are opposed to each other.
  • the rotation of the in-cylinder magnet 43 is prevented by the hooking of the stop piece 32a and the hooking portion 44a, and the magnetic repulsive force generated between the in-cylinder magnet 43 is attracted.
  • the counter magnet 46 is locked so as not to rotate.
  • the in-cylinder magnet 43 protrudes somewhat toward the cylinder tip side than the counter magnet 46.
  • the opposing magnet 46 When the stopper 51 is rotated, the opposing magnet 46 is unlocked. As shown in FIG. 7C, the counter magnet 46 is opposed to the cylinder magnet 43 with the same magnetic poles. The in-cylinder magnet 43 generates a magnetic repulsive force with the counter magnet 46 and is biased thereby to press the gasket 42. The drug solution 41 is discharged from the injection needle 22 through the tube tip 31 by sliding of the pressed gasket.
  • the syringe 10 can discharge the liquid medicine 41 simply by pinching the stopper 51 with a finger and moving the wrist with a slight force. Therefore, even a patient who is difficult to perform a fine operation with a fingertip can be easily injected. Further, since it is not necessary to use an adhesive to fix the fixing holder 47 in which the opposing magnet 46 is embedded to the cylinder 30, there is no possibility of contaminating the chemical liquid 41, and the syringe 10 is hygienic.
  • FIG. 7 shows an example in which the in-cylinder magnet 43 and the counter magnet 46 are magnetized with four poles in their circumferential direction. However, these magnets only need to be magnetized with at least two poles, It may be 6 poles or more.
  • the drug solution 41 accommodated in the cylinder 30 is, for example, a sugar solution injection solution such as glucose, an electrolyte correction injection solution such as sodium chloride or potassium lactate, an antiarrhythmic agent, an anticonvulsant, an insulin preparation, a protein preparation, an antibody drug, Antirheumatic drugs, bronchodilators, contrast agents, steroids, proteolytic enzyme inhibitors, fat emulsions, antibiotics, anticancer agents, heparin calcium, anesthetics, antibody drugs and the like can be mentioned.
  • a sugar solution injection solution such as glucose
  • an electrolyte correction injection solution such as sodium chloride or potassium lactate
  • an antiarrhythmic agent such as sodium chloride or potassium lactate
  • an anticonvulsant an insulin preparation
  • a protein preparation an antibody drug
  • Influenza tetanus, pneumococci, polio, Japanese encephalitis, rubella, measles, yellow fever, hives, hepatitis, chickenpox, rabies, rotavirus, mumps, cervical cancer prevention, MQ, DT and DPT vaccines
  • biopharmaceuticals Such biopharmaceuticals.
  • the inner diameter of the cylinder 30 is preferably 5 to 30 mm. If the inner diameter is smaller than this range, it is difficult to mold the cylinder 30. If it is larger than this range, the force for sliding the gasket 42 becomes large and a strong magnetic repulsive force is required. Therefore, the in-cylinder magnet 43 and the counter magnet 46 must be enlarged, and the syringe 10 becomes heavy. Portability is impaired.
  • the syringe 10 may be sterilized by any of ethylene oxide gas, ⁇ rays, electron beams, and high pressure steam in an autoclave.
  • the sterilization method and procedure are appropriately selected according to the material of the cylinder 30, the type and stability of the liquid medicine 41 to be injected, the size and shape of the syringe 10, and the like.
  • the material of the cylinder 30, the in-cylinder holder 44, the fixing holder 47, the stopper 51, the pressing hook 54, the locking pin 55, the pulling hook 56, and the lid 57 is chemical resistance, gas / bacteria barrier property, and safety to living bodies.
  • polyolefin resin such as polyethylene, polypropylene and cyclic polyolefin; polystyrene; polycarbonate; polyester such as polyethylene terephthalate;
  • a resin having high heat resistance, such as polypropylene or polycarbonate as these materials.
  • the material of the cylinder 30 it has a high transparency so that the drug solution 41 accommodated in the cylinder 30 can be visually recognized from the outside, has little interaction with the drug solution 41, and is strongly gripped when the drug solution 41 is administered. It is preferable to use a cyclic olefin homopolymer or a cyclic olefin copolymer, which is a resin that does not bend and does not collapse even when pressed.
  • a cyclic olefin homopolymer or a cyclic olefin copolymer which is a resin that does not bend and does not collapse even when pressed.
  • the molding method an injection molding method, a blow molding method, a thermoforming method, or the like can be used, and among these, the injection molding method is preferable.
  • the materials of the cap 21 and the gasket 42 are selected from the same viewpoint as described above.
  • rubber materials such as olefin-based, polyurethane-based, polyester-based, polyamide-based or styrene-based thermoplastic elastomers, natural rubber, isoprene rubber, butadiene rubber, styrene-butadiene rubber, and silicone rubber are used.
  • the syringe of the present invention is used for injecting a drug solution into a patient.
  • the chemical solution discharging method of the present invention is used for self-injection or injection at a medical institution.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Provided is a syringe which does not have a plunger, is small and has excellent portability, and is capable of discharging a drug solution with simple operation. The syringe (10) comprises a tube (30) that is provided with a nozzle (31) on a distal end and an opening (34) on a base end, a gasket (42) that is inserted into the tube (30) and slides by being pressed, and a drug solution (41) that is contained inside the tube (30) between the nozzle (31) and the gasket (42) and is discharged from the nozzle (31) by the sliding of the gasket (42). The syringe (10) further comprises a tube inner magnet (43) that is inserted inside the tube (30) and an opposing magnet (46) that is fixed to the tube (30) or surrounds the tube (30) and produces bias with a magnetic repulsive force that is generated by causing the opposing magnet (46) and the tube inner magnet (43) to oppose each other by like poles to cause sliding of the gasket (42) toward the distal end of the tube (30). At least one of the tube inner magnet (43) and the opposing magnet (46) is locked by the tube (30), and pressing is started by loading up bias until the lock is released or by producing bias after the lock is released.

Description

シリンジSyringe
 本発明は、プランジャを有さずとも、磁性斥力によってガスケットが摺動するシリンジに関するものである。 The present invention relates to a syringe in which a gasket slides by magnetic repulsion without having a plunger.
 シリンジは、薬液を患者等に注射する際に用いられる。シリンジは、先端に注射針が取り付けられ、基端に開口を有する筒と、これに挿入されそこで摺動するガスケットとを有するものである。このガスケットに、プランジャが取り付けられている。シリンジの開口から突き出したこのプランジャを、押すことによってガスケットが摺動し、筒内に予め収容された薬液を排出して注射することができる。このプランジャは、薬液を確実に排出させるためにガスケットを筒の筒先まで到達することができるように筒と同等以上の長さが必要である。 The syringe is used when injecting a drug solution into a patient or the like. The syringe has a cylinder having an injection needle attached to the distal end and an opening at the proximal end, and a gasket that is inserted into and slides there. A plunger is attached to the gasket. When the plunger protruding from the opening of the syringe is pushed, the gasket slides, and the medicine previously stored in the cylinder can be discharged and injected. This plunger needs to have a length equal to or longer than that of the cylinder so that the gasket can reach the end of the cylinder in order to reliably discharge the chemical solution.
 シリンジは、医師や看護師等によって医療現場で診療の際に用いられるだけでなく、糖尿病患者やリウマチ患者等によって薬液を自己注射する際にも用いられる。中でもプレフィルドシリンジは、薬液の菌の汚染防止と薬液調製の簡便とのために筒内に予め薬液が収容されているものである。 Syringes are used not only by medical doctors and nurses in medical practice, but also when self-injecting medicinal solutions by diabetics and rheumatic patients. Among these, prefilled syringes are prestored in a cylinder in order to prevent contamination of the bacteria of the chemical and simplify the preparation of the chemical.
 特許文献1に、薬剤懸濁液を収容したアンプルの一端をピストンで閉じ、ピストンに金属含有固定部材を設けて磁力で懸濁液中のビーズのような磁気部材を引き寄せておき、手動で振盪して混合部材を放して懸濁液を拡散させる投与装置が開示されている。これらのシリンジや投与装置は、筒内のガスケットを摺動させるためにプランジャを必要とする。 In Patent Document 1, one end of an ampoule containing a drug suspension is closed with a piston, a metal-containing fixing member is provided on the piston, and a magnetic member such as a bead in the suspension is attracted magnetically, and shaken manually. An administration device is then disclosed in which the mixing member is released to diffuse the suspension. These syringes and administration devices require a plunger to slide the gasket in the cylinder.
 従来のシリンジは、プランジャの所為でシリンジの全長が長い。さらに、このプランジャを押す際に指を掛ける筒基端のフランジを設けなければならず、このフランジの分だけシリンジの全幅が大きかった。 The conventional syringe is long due to the plunger. In addition, a flange at the base end of the cylinder to which a finger is applied when the plunger is pushed has to be provided, and the entire width of the syringe is large by this flange.
 このようなシリンジは、注射の際、フランジに先端側で人差し指と中指を掛けつつ、親指でプランジャの基端を押圧して筒内に力強く押し込む動作が必要である。また近年、自己注射に用いられる針は、注射時の痛みを軽減させるのに、針の先端を細くする工夫がなされている。さらに、ワクチンなどの生物製剤の注入量が少量で済むように、免疫担当細胞が多く存在する表皮乃至真皮のような皮膚上層部に細径の短い注射針で薬液を注入することがある。これらの細い注射針を用いる場合、薬液が注射針を通過する際の抵抗が大きくなり、強い注入力が必要になる。 Such a syringe requires an operation of pressing the proximal end of the plunger with the thumb and pushing it into the cylinder with force while placing the index finger and the middle finger on the front end of the flange during injection. In recent years, needles used for self-injection have been devised to reduce the tip of the needle in order to reduce pain during injection. In addition, a liquid medicine may be injected with a small-diameter injection needle into the upper layer of the skin such as the epidermis or dermis where many immunocompetent cells are present so that the injection amount of a biologic such as a vaccine may be small. When these thin injection needles are used, resistance when the drug solution passes through the injection needle is increased, and strong injection force is required.
 疾病によって手が不自由となったり、高齢で充分な力が入らなかったりして、この動作が困難な患者は、自己注射することが難しい。 It is difficult for patients who have difficulty in this movement because their hands become inconvenient due to illness or because they are old and do not have enough force.
 シリンジは、自己注射に用いられる場合、患者が適時に注射できるよう小型で軽く、高い注入力が必要であっても簡易にわずかな力で注射でき、携帯し易いものが望まれていた。 When a syringe is used for self-injection, it is desired that the syringe be small and light so that the patient can inject it in a timely manner, and can be easily injected with little force even when high injection input is required, and easy to carry.
特表2001-511033号公報JP-T-2001-511033
 本発明は前記の課題を解決するためになされたもので、プランジャを有さず小型で携帯性に優れ、簡易な動作で薬液を排出することができるシリンジを提供することを目的とする。 The present invention has been made to solve the above-described problems, and an object of the present invention is to provide a syringe that does not have a plunger, is small and excellent in portability, and can discharge a chemical solution with a simple operation.
 前記の目的を達成するためになされた本発明のシリンジは、先端部に筒先、及び基端部に開口が設けられた筒と、前記筒に挿入され、押圧により摺動するガスケットと、前記筒内で前記筒先及び前記ガスケットの間に収容され前記ガスケットの摺動により前記筒先から排出される薬液とを有するシリンジであって、前記筒に挿入されている筒内磁石と、前記筒に固定され又は前記筒を取り囲んでおり、前記筒内磁石と同磁極同士で対向させることによって生じる磁性斥力で、付勢を生じさせて前記先端部への前記ガスケットの前記摺動を誘発する対向磁石とを、備え、前記筒内磁石と前記対向磁石との少なくとも何れかが、前記筒に係止されており、その係止を解除するまで前記付勢を溜め、又はその係止を解除させてから前記付勢を生じさせて、前記押圧を開始させるものである。 The syringe of the present invention, which has been made to achieve the above object, includes a cylinder having a cylinder tip at the tip and an opening at the base, a gasket that is inserted into the cylinder and slides by pressing, and the cylinder A syringe that is contained between the cylinder tip and the gasket and is discharged from the cylinder tip by sliding of the gasket, and is fixed to the cylinder and an in-cylinder magnet inserted into the cylinder. Alternatively, a counter magnet that surrounds the cylinder and generates a bias with a magnetic repulsive force generated by causing the same magnetic pole to face the in-cylinder magnet to induce the sliding of the gasket to the tip portion. And at least one of the in-cylinder magnet and the counter magnet is locked to the cylinder, and the bias is accumulated until the locking is released, or the locking is released and then the locking is released. Cause energization So, in which to start the press.
 シリンジは、前記筒内磁石と、前記対向磁石とが、互いに同磁極同士で対向しつつ前記磁性斥力に反して押し付け合うことによって、前記付勢を生じさせており、ストッパが、前記筒内磁石を係止していることによって、前記付勢を溜めていることが好ましい。 The syringe generates the bias by pressing the in-cylinder magnet and the counter magnet against the magnetic repulsive force while facing each other with the same magnetic poles, and the stopper includes the in-cylinder magnet. It is preferable that the urging force is accumulated by locking.
 シリンジは、側面に嵌合部を有する筒内ホルダに前記筒内磁石が埋め込まれており、前記ストッパが前記嵌合部に嵌合していることによって、前記筒内磁石を係止していてもよい。 In the syringe, the in-cylinder magnet is embedded in an in-cylinder holder having a fitting portion on a side surface, and the stopper is fitted in the fitting portion, thereby locking the in-cylinder magnet. Also good.
 シリンジは、前記嵌合部が、前記筒内ホルダの周方向に窪み前記筒内磁石ごと前記筒内ホルダを係止させている溝と、前記筒内ホルダの中心軸方向に窪み前記係止を解除する溝とを、連結させているものであることが好ましい。 In the syringe, the fitting portion is recessed in the circumferential direction of the in-cylinder holder, and a groove for locking the in-cylinder holder together with the in-cylinder magnet is depressed in the central axis direction of the in-cylinder holder. It is preferable that the groove to be released is connected.
 シリンジは、前記ストッパと前記嵌合部との嵌合を前記筒の外側から外して、前記係止を解除するフックが、前記ストッパに設けられていてもよい。 The syringe may be provided with a hook for releasing the locking by removing the fitting between the stopper and the fitting portion from the outside of the cylinder.
 シリンジは、前記筒内磁石と、前記筒内磁石ごと前記筒を取り囲んでいる環状の前記対向磁石とが、夫々の側面の周方向で着磁されて、異磁極同士の対向で磁性引力を生じつつ、ストッパが、前記対向磁石を回動不能に係止していることにより、前記係止を解除させてから前記付勢を生じさせることが好ましい。 In the syringe, the in-cylinder magnet and the annular counter magnet that surrounds the cylinder together with the in-cylinder magnet are magnetized in the circumferential direction of the respective side surfaces, and magnetic attractive force is generated by opposing the different magnetic poles. On the other hand, it is preferable that the urging is generated after the stopper is released by stopping the counter magnet in a non-rotatable manner.
 シリンジは、前記筒内磁石及び前記対向磁石が、ラジアル異方性磁石であってもよい。 In the syringe, the in-cylinder magnet and the counter magnet may be radial anisotropic magnets.
 シリンジは、前記筒内磁石が、筒内ホルダに埋め込まれていてもよい。 In the syringe, the in-cylinder magnet may be embedded in an in-cylinder holder.
 シリンジの薬液排出方法は、先端部に筒先、及び基端部に開口が設けられた筒と、前記筒に挿入され押圧により摺動するガスケットと、前記筒内で前記筒先及び前記ガスケットの間に収容され前記ガスケットの摺動で前記筒先から排出される薬液とを有するシリンジから、前記薬液を排出する方法であって、前記筒に筒内磁石を挿入する工程、前記筒内磁石へ同磁極同士で対向させる対向磁石を、それらの磁性斥力により付勢させ又は付勢できるように前記筒に固定し又は前記筒に取り囲ませる工程、前記筒内磁石と前記対向磁石との少なくとも何れかを係止し、その係止を解除するまで前記付勢を溜め、又はその係止を解除させてから前記付勢を生じさせる工程、前記係止の解除に応じ、前記付勢によって、前記筒内磁石で前記ガスケットに前記先端部への前記摺動を誘発させて、前記押圧を生じさせて前記薬液を排出する工程を有するものである。 The syringe liquid discharge method includes: a cylinder tip at the tip, and a cylinder provided with an opening at the base end; a gasket that is inserted into the cylinder and slides by pressing; and the cylinder tip and the gasket in the cylinder A method of discharging the chemical liquid from a syringe having a chemical liquid stored and discharged from the tip of the cylinder by sliding of the gasket, the step of inserting an in-cylinder magnet into the cylinder, The step of fixing the opposing magnets to be opposed to each other by the magnetic repulsive force so as to be energized or energized by the magnetic repulsive force, or enclosing at least one of the in-cylinder magnet and the opposing magnet. Then, the biasing is accumulated until the locking is released, or the step of generating the biasing after the locking is released, the biasing is performed by the in-cylinder magnet according to the release of the locking. The gasket Said to induce the sliding movement of the tip, and has a step of discharging the chemical solution causing the pressing.
 本発明のシリンジは、筒に固定され又は筒内磁石を取り囲んでいる対向磁石と、筒内に挿入されている筒内磁石との間の磁性斥力で、筒内磁石が付勢され、ガスケットを摺動させるので、筒に挿入するプランジャや筒基端で突き出るフランジを必要としない。そのため、シリンジを短く細くして小型にできるので、特に自己注射をする患者が、携帯するのに便利である。 In the syringe of the present invention, the in-cylinder magnet is urged by the magnetic repulsion between the opposing magnet fixed to the cylinder or surrounding the in-cylinder magnet and the in-cylinder magnet inserted in the cylinder, Since it is slid, a plunger inserted into the cylinder and a flange protruding at the base end of the cylinder are not required. Therefore, since the syringe can be shortened and made small, it is particularly convenient for a patient who performs self-injection to carry.
 このシリンジは、手の不自由な患者や指手の力の弱い高齢者であっても、筒内磁石又は対向磁石を係止しているストッパを、わずかな力で押したり、指を掛けて引っ張ったり、摘んで回動させたりするだけで、容易く薬液を排出して注射することができる。また、医療現場で、素早く簡易な操作で誤作動なく簡便に注射することができる。 Even if the syringe is a handicapped patient or an elderly person with weak finger strength, the syringe that holds the in-cylinder magnet or the opposing magnet is pushed with a slight force or a finger is applied. The drug solution can be easily discharged and injected simply by pulling or picking and rotating. In addition, it is possible to simply inject at a medical site by a quick and simple operation without malfunction.
 このシリンジは、ストッパを回動させるだけで、ガスケットの摺動を逐次止め、薬液を必要な用量毎に小出しに排出して注射することができる。 This syringe can stop the sliding of the gasket by simply rotating the stopper, and discharge the medicine into small doses for each required dose for injection.
 シリンジから薬液を排出する方法によれば、簡易な動作で薬液の排出操作を簡便に行うことができる。 According to the method of discharging the chemical solution from the syringe, the discharge operation of the chemical solution can be easily performed with a simple operation.
本発明を適用するシリンジの一形態を示す分解斜視図及び斜視図である。It is the disassembled perspective view and perspective view which show one form of the syringe to which this invention is applied. 本発明を適用するシリンジの一形態を示す一部切欠き部分斜視図である。It is a partial notch partial perspective view which shows one form of the syringe to which this invention is applied. 本発明を適用するシリンジの別な形態を示す斜視図である。It is a perspective view which shows another form of the syringe to which this invention is applied. 本発明を適用するシリンジの別な形態を示す部分斜視図である。It is a fragmentary perspective view which shows another form of the syringe to which this invention is applied. 本発明を適用するシリンジの別な形態を示す部分斜視図である。It is a fragmentary perspective view which shows another form of the syringe to which this invention is applied. 本発明を適用するシリンジの別な形態を示す部分斜視図である。It is a fragmentary perspective view which shows another form of the syringe to which this invention is applied. 本発明を適用するシリンジの別な形態を示す斜視図及び磁極の位置を説明する模式斜視図である。It is a perspective view which shows another form of the syringe to which this invention is applied, and a model perspective view explaining the position of a magnetic pole.
 以下、本発明を実施するための形態を詳細に説明するが、本発明の範囲は、これらの実施形態に限定されるものではない。 Hereinafter, modes for carrying out the present invention will be described in detail, but the scope of the present invention is not limited to these embodiments.
 本発明のシリンジ10の一形態を図1に示す。図1(a)は、シリンジ10の分解斜視図であり、同図(b)は、シリンジ10を組立てた状態を示す斜視図である。シリンジ10は、筒30と、その筒先31に接合した注射針22と、筒30の開口34に嵌められた固定ホルダ47と、筒30の側壁の一部を取り囲んでいるストッパ51とを有している。 FIG. 1 shows an embodiment of the syringe 10 of the present invention. FIG. 1A is an exploded perspective view of the syringe 10, and FIG. 1B is a perspective view showing a state in which the syringe 10 is assembled. The syringe 10 includes a cylinder 30, an injection needle 22 joined to the cylinder tip 31, a fixed holder 47 fitted in the opening 34 of the cylinder 30, and a stopper 51 that surrounds a part of the side wall of the cylinder 30. ing.
 筒30は、内部を視認できるように、透明な材質で成形されている。筒30は、先端部に縮径した筒先31が形成されており、基端部に開口34が設けられているものである。筒30に、ガスケット42が挿入されている。筒30内で筒先31とガスケット42との間に、薬液41が収容されている。ガスケット42は、筒30の内壁面と気密に密着していることにより、薬液41の漏れを防止している。ガスケット42は、筒内磁石43を埋め込んだ略円柱形状の筒内ホルダ44と一体化している。 The cylinder 30 is formed of a transparent material so that the inside can be visually confirmed. The tube 30 is formed with a tube tip 31 having a reduced diameter at a distal end portion and an opening 34 provided at a proximal end portion. A gasket 42 is inserted into the cylinder 30. A chemical solution 41 is accommodated between the tube tip 31 and the gasket 42 in the tube 30. The gasket 42 is in close contact with the inner wall surface of the cylinder 30 in an airtight manner, thereby preventing the chemical liquid 41 from leaking. The gasket 42 is integrated with a substantially cylindrical in-cylinder holder 44 in which an in-cylinder magnet 43 is embedded.
 シリンジは、筒内ホルダ44と筒30の内壁面とが、互いに回動不能に引っ掛け合っている。例えば、筒30の中心軸に平行な直線状の回止片32aが、筒30の内壁面で僅かに出っ張っている。筒内ホルダ44の側面で窪んでいる掛止部44aは、筒内ホルダ44の中心軸と平行に設けられており、回止片32aと互いに引っ掛け合っている。それにより回止片32a及び掛止部44aは、ストッパ51の回動に連れて筒内ホルダ44が回動することを防止している。回止片32aは、ガスケット42を傷つけないように、滑らかな弧をなしている。 In the syringe, the in-cylinder holder 44 and the inner wall surface of the cylinder 30 are hooked so as not to rotate. For example, a linear rotation piece 32 a parallel to the central axis of the cylinder 30 slightly protrudes from the inner wall surface of the cylinder 30. The latching portion 44a that is recessed on the side surface of the in-cylinder holder 44 is provided in parallel with the central axis of the in-cylinder holder 44 and is hooked to the rotation piece 32a. Thereby, the rotation piece 32a and the latching portion 44a prevent the in-cylinder holder 44 from rotating as the stopper 51 rotates. The rotation stop piece 32a forms a smooth arc so as not to damage the gasket 42.
 筒先31は、胴部32よりも縮径している。その先端から注射針22が突き出している。注射針22は、筒先31を貫通しており、筒30の内外を連通させている。筒先31に、弾性体であるキャップ21が、取り付けられている。キャップ21は、注射針22で突き刺さされている。それによって筒30を密封し、シリンジ10の輸送時や保管時に筒30内の薬液41が漏れたり汚染されたりすることを防止している。 The tube tip 31 has a diameter smaller than that of the body portion 32. The injection needle 22 protrudes from the tip. The injection needle 22 penetrates the tube tip 31 and communicates the inside and outside of the tube 30. A cap 21 that is an elastic body is attached to the tube tip 31. The cap 21 is pierced with an injection needle 22. Thereby, the cylinder 30 is sealed, and the chemical solution 41 in the cylinder 30 is prevented from leaking or being contaminated when the syringe 10 is transported or stored.
 図2(a)に、シリンジ10の一部切欠き部分斜視図を示す。筒内ホルダ44のガスケット42側の端面で、T字形状の断面である鉤部44bが突き出している。鉤部44bは、ガスケット42の筒内ホルダ44側の端面に開けられた穴42aに挿入されている。ガスケット42は、弾性を有する材料で成形されて柔軟性に富んでいる。それにより、穴42aに鉤部44bを容易に押し込むことができる。筒内ホルダ44は、ガスケット42とともに、筒30に挿入されている。 FIG. 2 (a) shows a partially cutaway partial perspective view of the syringe 10. FIG. On the end face of the in-cylinder holder 44 on the gasket 42 side, a flange portion 44b having a T-shaped cross section protrudes. The flange portion 44b is inserted into a hole 42a formed in the end surface of the gasket 42 on the cylinder holder 44 side. The gasket 42 is molded from an elastic material and is highly flexible. Thereby, the collar part 44b can be easily pushed into the hole 42a. The in-cylinder holder 44 is inserted into the cylinder 30 together with the gasket 42.
 筒内磁石43は、両端面に磁極を有する永久磁石であって、筒30の先端部側の面がS極、基端部側の面がN極である。 The in-cylinder magnet 43 is a permanent magnet having magnetic poles at both end surfaces, and the surface on the distal end side of the cylinder 30 is an S pole and the surface on the proximal end side is an N pole.
 筒内ホルダ44は、側面に嵌合部45を有している。嵌合部45は、筒内ホルダ44の円周方向に窪んだ係止溝45aと、筒内ホルダ44の中心軸方向に窪んだ解除溝45bとが略直角に連結している溝である。嵌合部45は、筒内ホルダ44の中心軸を対称軸とする線対称に、2つ設けられている。筒30の側壁を貫通している貫通孔33から、係止溝45aが露呈している(図1(b)参照)。 The cylinder holder 44 has a fitting portion 45 on the side surface. The fitting portion 45 is a groove in which a locking groove 45 a that is recessed in the circumferential direction of the in-cylinder holder 44 and a release groove 45 b that is recessed in the central axis direction of the in-cylinder holder 44 are connected at a substantially right angle. Two fitting portions 45 are provided in line symmetry with the central axis of the in-cylinder holder 44 as the symmetry axis. A locking groove 45a is exposed from the through hole 33 penetrating the side wall of the cylinder 30 (see FIG. 1B).
 開口34に、対向磁石46が埋め込まれた固定ホルダ47が嵌められ接着又は熱溶着によって固設されている。対向磁石46は、両端面に磁極を有する永久磁石であって、筒30の先端部側の面がN極、基端部側の面がS極である。対向磁石46は、筒内磁石43とN極同士を対向させていることによって、互いを斥け合う磁性斥力を生じさせている。筒内磁石43は、この磁性斥力に反して対向磁石46に押し付けられていることによって、付勢されている。 A fixed holder 47 in which a counter magnet 46 is embedded is fitted in the opening 34 and fixed by adhesion or heat welding. The counter magnet 46 is a permanent magnet having magnetic poles at both end surfaces, and the surface on the distal end side of the cylinder 30 is an N pole and the surface on the proximal end side is an S pole. The counter magnet 46 generates a magnetic repulsive force that generates a mutual repelling force by causing the in-cylinder magnet 43 and the N poles to face each other. The in-cylinder magnet 43 is urged by being pressed against the opposing magnet 46 against this magnetic repulsion.
 ストッパ51は、半円筒形状をなしている。ストッパ51の内壁面で、係止突起52が対称位置に2つ突き出している。係止突起52は、貫通孔33を経て係止溝45aに嵌合している。これにより、ストッパ51は、薬液41の排出時まで、ガスケット42が押圧されないように、筒内磁石43を係止するとともに、筒内磁石43の付勢を溜めている。ストッパ51は、図2(a)に示す矢印方向に、回動できる。ストッパ51の外周は、指で摘み易いように、窪んでいる。 The stopper 51 has a semi-cylindrical shape. On the inner wall surface of the stopper 51, two locking projections 52 protrude in symmetrical positions. The locking projection 52 is fitted into the locking groove 45 a through the through hole 33. Thereby, the stopper 51 holds the in-cylinder magnet 43 and keeps the bias of the in-cylinder magnet 43 so that the gasket 42 is not pressed until the chemical solution 41 is discharged. The stopper 51 can be rotated in the direction of the arrow shown in FIG. The outer periphery of the stopper 51 is recessed so that it can be easily picked with a finger.
 図2(a)に示すように、ストッパ51の係止突起52は、係止溝45aに係止されているが、ストッパ51の回動により解除溝45bに移動することができる。図2(b)に、ストッパ51による係止が解除されたシリンジ10の一部切欠き部分斜視図を示している。筒内磁石43は、係止が解除されると、溜められた付勢によって、ガスケット42を筒内ホルダ44ごと筒30の先端部方向に押圧し、摺動させるようになっている。薬液41は、摺動するガスケット42によって、筒先31を経て注射針22から排出することができる。 As shown in FIG. 2A, the locking projection 52 of the stopper 51 is locked to the locking groove 45a, but can be moved to the release groove 45b by the rotation of the stopper 51. FIG. 2B shows a partially cutaway partial perspective view of the syringe 10 released from the locking by the stopper 51. When the latching is released, the in-cylinder magnet 43 presses and slides the gasket 42 together with the in-cylinder holder 44 toward the distal end portion of the cylinder 30 by the accumulated bias. The drug solution 41 can be discharged from the injection needle 22 through the tube tip 31 by the sliding gasket 42.
 このように、シリンジ10は、ガスケット42を押圧するプランジャ及びこのプランジャを押す際に指を掛ける基端フランジを有していなくても、筒30内に収容された薬液41を排出することができる。その結果、このシリンジ10の全長を、プランジャを用いる場合に比較して短くすることができる。また、誤ってプランジャを引き抜いてしまう恐れが無いので、薬液41が密封されたまま汚染されず、シリンジ10は、安全である。 Thus, even if the syringe 10 does not have a plunger that presses the gasket 42 and a proximal flange that hooks a finger when the plunger 10 is pressed, the syringe 41 can discharge the chemical solution 41 contained in the cylinder 30. . As a result, the overall length of the syringe 10 can be shortened compared to the case where a plunger is used. Moreover, since there is no possibility that the plunger is accidentally pulled out, the chemical solution 41 is not contaminated while being sealed, and the syringe 10 is safe.
 筒内磁石43と対向磁石46との間に生じた磁性斥力の強さは、それら磁石の形状及び表面積が一定条件下、磁石の表面磁束密度に依る。この表面磁束密度が、高いほど磁性斥力が強くなり、逆に低いほど弱くなる。そのため、この表面磁束密度は、筒内磁石43に付勢を生じさせ、ガスケット42を押圧して摺動させる力に影響を与える。磁石の表面磁束密度は、100~30000Gであると好ましく、100~20000Gであると一層好ましく、1000~10000Gであるとなお一層好ましい。表面磁束密度がこの範囲よりも小さいと、磁性斥力が不足して、筒内磁石43を十分に付勢させることができないため、ガスケット42を押圧できない。一方この範囲よりも大きいと、磁石が強磁力であるので高価になって経済的に実用でないばかりか、それが有する磁性によって周辺の医療機器に誤作動を生じる恐れがある。磁石の磁束密度は、筒30の外内径、ガスケット34の摺動抵抗、薬液33の粘度、注射針21の内径及び長さ、注射すべき部位等に応じ、適宜設定される。 The strength of the magnetic repulsion generated between the in-cylinder magnet 43 and the counter magnet 46 depends on the surface magnetic flux density of the magnet under the condition that the shape and surface area of the magnets are constant. The higher the surface magnetic flux density, the stronger the magnetic repulsion, and vice versa. For this reason, the surface magnetic flux density exerts an urging force on the in-cylinder magnet 43 and affects the force that presses and slides the gasket 42. The surface magnetic flux density of the magnet is preferably from 100 to 30000 G, more preferably from 100 to 20000 G, and even more preferably from 1000 to 10000 G. If the surface magnetic flux density is smaller than this range, the magnetic repulsive force is insufficient, and the in-cylinder magnet 43 cannot be sufficiently biased, so that the gasket 42 cannot be pressed. On the other hand, if it is larger than this range, the magnet is a strong magnetic force, so that it becomes expensive and not economically practical, and there is a risk of causing malfunctions in peripheral medical devices due to the magnetism of the magnet. The magnetic flux density of the magnet is appropriately set according to the outer diameter of the cylinder 30, the sliding resistance of the gasket 34, the viscosity of the drug solution 33, the inner diameter and length of the injection needle 21, the site to be injected, and the like.
 筒内磁石43及び対向磁石46の磁石として、ネオジム磁石、アルニコ磁石、サマリウムコバルト磁石、又はフェライト磁石が挙げられる。中でもネオジム磁石は、磁性斥力が大きい利点がある。アルニコ磁石は、機械的強度に優れ、任意の形状に成型できる。サマリウムコバルト磁石は、温度によって表面磁束密度が変化し難いので、任意の温度下でも使用できる。 As the magnets of the in-cylinder magnet 43 and the counter magnet 46, a neodymium magnet, an alnico magnet, a samarium cobalt magnet, or a ferrite magnet can be given. Among these, neodymium magnets have the advantage of large magnetic repulsion. Alnico magnets have excellent mechanical strength and can be molded into any shape. Since the surface magnetic flux density hardly changes depending on the temperature, the samarium cobalt magnet can be used at any temperature.
 図1に示すシリンジ10は、以下のようにして製造される。先ず、インサート成形によって筒30を成型しつつ、注射針22を筒先31に直接接合する。弾性体であるキャップ21を、注射針22をまっすぐに突き刺して筒先31に取り付け、注射針22の針先を封止する。これに高圧蒸気滅菌等の滅菌処理を施す。次いで、筒30内に所望の薬液41を充填する。筒内ホルダ44の鉤部44bを、ガスケット42の穴42aに押し込み、両者を一体化する。筒内ホルダ44の側面で窪んでいる掛止部44aに、回止片32aを嵌めながら、ガスケット42と筒内ホルダ44とを筒30内に押し込んで、薬液41を密封する。ストッパ51の材質は、筒30の材質よりも多少柔軟性を有するものである。ストッパ51を、一旦撓ませて押し開き、両係止突起52が筒30の貫通孔33を経て係止溝45aに嵌り込ませる。すると、ストッパ51は自身の多少の弾力性によって復元する。両係止突起52が係止溝45aに引っ掛かり、筒内磁石43ごと筒内ホルダ44が係止される。対向磁石46と一体化した固定ホルダ47を、開口34から嵌めて、磁性斥力に反するように押し込み、接着剤で接着又は熱溶着して固定する。シリンジ10を、ブリスター包装材内に収納し、必要に応じ滅菌する。なお、薬液41の充填されたシリンジ10を滅菌してからブリスター包装材内に収納してもよい。 The syringe 10 shown in FIG. 1 is manufactured as follows. First, the injection needle 22 is directly joined to the tube tip 31 while the tube 30 is formed by insert molding. The cap 21, which is an elastic body, is attached to the tube tip 31 by piercing the injection needle 22 straight, and the needle tip of the injection needle 22 is sealed. This is subjected to sterilization such as high-pressure steam sterilization. Next, a desired chemical solution 41 is filled into the cylinder 30. The flange portion 44b of the in-cylinder holder 44 is pushed into the hole 42a of the gasket 42 to integrate them. The gasket 42 and the in-cylinder holder 44 are pushed into the cylinder 30 and the drug solution 41 is sealed while the rotation piece 32a is fitted in the latching portion 44a that is recessed on the side surface of the in-cylinder holder 44. The material of the stopper 51 is somewhat more flexible than the material of the cylinder 30. The stopper 51 is bent once and pushed open, and both locking projections 52 are fitted into the locking grooves 45 a through the through holes 33 of the cylinder 30. Then, the stopper 51 is restored by its own elasticity. Both the locking projections 52 are caught in the locking groove 45 a, and the in-cylinder holder 44 is locked together with the in-cylinder magnet 43. A fixing holder 47 integrated with the counter magnet 46 is fitted from the opening 34, pushed in so as to oppose the magnetic repulsive force, and fixed by bonding or heat welding with an adhesive. The syringe 10 is housed in a blister packaging material and sterilized as necessary. The syringe 10 filled with the chemical solution 41 may be sterilized and then stored in the blister packaging material.
 シリンジ10は、患者自身が自己注射に使用する場合、以下のようにして使用される。医師・看護師、又は自己注射する患者は、ブリスター包装材の台紙を剥がしてシリンジ10を取り出し、筒先31に嵌められていたキャップ21を外す。胴部32を支えてシリンジ10を持つ。上腕部、腹部又は大腿部等の注射すべき部位の例えば皮下に、注射針22を穿刺する。注射すべき部位から注射針22が抜けないようにシリンジ10を固定しながらストッパ51を、図2(a)に示す矢印方向へ回す。係止突起52は、係止溝45aから解除溝45bに移動して係止を解除するとともに解除溝45b上を滑って、遂には解除溝45bから抜ける。それによって、筒内磁石43の係止が解けるので、磁性斥力による付勢によって筒内磁石43が筒内ホルダ44ごとガスケット42を押圧し、ガスケット42が筒先31に向って摺動する。薬液41は、注射針22を通じて筒30から排出されて、患者の体内へと注入される。注射針22ごとシリンジ10を体外へ外す。シリンジ10を、感染性医療廃棄物として廃棄する。なお、ストッパ51を、シリンジ10の廃棄前に筒30から外して再度使用してもよく、この場合、薬液41はカートリッジ式の詰め替え形態となっていてもよい。 The syringe 10 is used as follows when the patient himself uses it for self-injection. The doctor / nurse or the patient to be self-injected removes the mount of the blister packaging material, takes out the syringe 10, and removes the cap 21 fitted to the tube tip 31. The body 10 is held and the syringe 10 is held. The injection needle 22 is punctured, for example, subcutaneously at a site to be injected, such as the upper arm, abdomen, or thigh. The stopper 51 is rotated in the direction of the arrow shown in FIG. 2A while fixing the syringe 10 so that the injection needle 22 does not come out of the site to be injected. The locking projection 52 moves from the locking groove 45a to the release groove 45b to release the lock, slides on the release groove 45b, and finally comes out of the release groove 45b. As a result, the in-cylinder magnet 43 is unlocked, and the in-cylinder magnet 43 presses the gasket 42 together with the in-cylinder holder 44 by urging by the magnetic repulsive force, and the gasket 42 slides toward the cylinder tip 31. The drug solution 41 is discharged from the cylinder 30 through the injection needle 22 and injected into the patient's body. The syringe 10 together with the injection needle 22 is removed from the body. The syringe 10 is discarded as infectious medical waste. The stopper 51 may be removed from the cylinder 30 and reused before the syringe 10 is discarded. In this case, the chemical solution 41 may be in a cartridge-type refill form.
 図1及び図2に、筒内磁石43を埋め込んだ筒内ホルダ44と、ガスケット42とが一体化している例を示したが、両者が未使用状態で分離しており、筒内磁石43がガスケット42と開口34との間に挿入されていてもよい(不図示)。この場合筒内ホルダ44は、ストッパ51の回動により、付勢を溜めている筒内磁石43の係止が解除されると、この付勢によってガスケット42に当接し、ガスケット42を押圧して摺動させる。それにより、薬液41が排出される。 1 and 2 show an example in which the in-cylinder holder 44 in which the in-cylinder magnet 43 is embedded and the gasket 42 are integrated. However, both are separated in an unused state, and the in-cylinder magnet 43 is It may be inserted between the gasket 42 and the opening 34 (not shown). In this case, when the in-cylinder holder 43 is released from being locked by the rotation of the stopper 51, the in-cylinder holder 44 abuts on the gasket 42 by this urging and presses the gasket 42. Slide. Thereby, the chemical liquid 41 is discharged.
 なお、胴部32の側壁に、貫通孔33と開口34の周縁とを繋ぐスリット(不図示)を設けてもよい。係止突起52を、開口34からこのスリットに嵌めて、筒30の先端部へとスライドさせることによって、ストッパ51を押し広げることなく、係止溝45aに嵌めることができる。 A slit (not shown) that connects the through hole 33 and the periphery of the opening 34 may be provided on the side wall of the body portion 32. By fitting the locking projection 52 into the slit from the opening 34 and sliding it to the tip of the cylinder 30, the locking projection 52 can be fitted into the locking groove 45a without spreading.
 注射針22は、針基(不図示)に接合されていてもよい。注射針22は、この針基が筒先31に取り付けられることによって、筒30の内外を連通させる。 The injection needle 22 may be joined to a needle base (not shown). The needle 22 is connected to the inside and outside of the cylinder 30 by attaching the needle base to the cylinder tip 31.
 図3に、別なシリンジ10の実施形態の斜視図を示す。固定ホルダ47は、それの筒先側の端面周縁から、2本の爪47aが対称に突き出している。固定ホルダ47は、爪47aが解除溝45bに嵌められつつ、開口34に嵌められて接着又は溶着によって固定される。爪47aは、ストッパ51の回動に連れて筒内ホルダ44が回動することを防止する。解除溝45bは、ストッパ51を回したときに筒内ホルダ44の回動を防止する機能と、ストッパ51を回し切ったときに係止突起52を滑らせて筒内ホルダ44を移動させる機能とを併せ持つ。そのため部品点数を少なくすることができる。 FIG. 3 shows a perspective view of another embodiment of the syringe 10. The fixed holder 47 has two claws 47a projecting symmetrically from the peripheral edge of the end of the tube tip. The fixing holder 47 is fixed by adhesion or welding by being fitted into the opening 34 while the claw 47a is fitted in the release groove 45b. The claw 47 a prevents the in-cylinder holder 44 from rotating as the stopper 51 rotates. The release groove 45b has a function of preventing the in-cylinder holder 44 from rotating when the stopper 51 is rotated, and a function of moving the in-cylinder holder 44 by sliding the locking projection 52 when the stopper 51 is fully rotated. Have both. Therefore, the number of parts can be reduced.
 図4に、別なシリンジ10の実施形態の斜視図を示す。シリンジ10は、ガスケット42を段階的に摺動させることができるものである。シリンジ10は、筒30と、これに挿入されたガスケット42と、このガスケット42と一体化し、筒内磁石43が埋め込まれた筒内ホルダ44と、開口34に固定され、対向磁石46が埋め込まれた固定ホルダ47と、ストッパ51とを有している。筒内磁石43と対向磁石46とは、N極同士で対向している。それら磁石間で生じた磁性斥力によって、筒内磁石43は、付勢されている。 FIG. 4 shows a perspective view of another embodiment of the syringe 10. The syringe 10 can slide the gasket 42 in stages. The syringe 10 is fixed to the cylinder 30, the gasket 42 inserted therein, the cylinder holder 44 in which the cylinder magnet 43 is embedded, and the opening magnet 34, and the counter magnet 46 is embedded. A fixed holder 47 and a stopper 51 are provided. The in-cylinder magnet 43 and the counter magnet 46 are opposed to each other with N poles. The in-cylinder magnet 43 is urged by a magnetic repulsion generated between the magnets.
 筒内ホルダ44の側面に嵌合部45が設けられている。嵌合部45は、筒内ホルダ44の周方向に窪んだ係止溝45a,45cと、筒内ホルダ44の中心軸方向に窪んだ解除溝45b,45dとを有する溝である。この嵌合部45は、筒内ホルダ44の側面で、線対称に2本設けられている。嵌合部45は、ガスケット42側から、第1の係止溝45a、第1の解除溝45b、第2の係止溝45c及び第2の解除溝45dの順で夫々略直角に連結している。 A fitting portion 45 is provided on the side surface of the in-cylinder holder 44. The fitting portion 45 is a groove having locking grooves 45 a and 45 c that are recessed in the circumferential direction of the in-cylinder holder 44 and release grooves 45 b and 45 d that are recessed in the central axis direction of the in-cylinder holder 44. Two fitting portions 45 are provided in line symmetry on the side surface of the in-cylinder holder 44. The fitting portion 45 is connected to the gasket 42 from the side of the first locking groove 45a, the first release groove 45b, the second lock groove 45c, and the second release groove 45d in a substantially right angle. Yes.
 図4(a)に示すように、係止突起52は、第1の係止溝45aに嵌合していることにより、筒内磁石43ごと筒内ホルダ44を係止している。対向磁石46との間で生じた磁性斥力に反して押し付けられて係止されていることによって、筒内磁石43は、付勢を溜めている。ストッパ51が矢印の方向に回動すると、係止突起52は、第1の係止溝45aと第1の解除溝45bとが連結している略直角部に移動する(図4(b))。これによって係止が解除された筒内磁石43は、溜められた付勢によって、ガスケット42を筒先31へ向かって押圧する。係止突起52は、第1の解除溝45bを滑り、これと第2の係止溝45cとが連結している略直角部に移動し、その係止溝45cに当接する(図4(c))。これにより筒内磁石43は、再度係止される。当初筒30内に収容されていた量の半分量の薬液41が、排出される。 As shown in FIG. 4A, the locking protrusion 52 locks the in-cylinder holder 44 together with the in-cylinder magnet 43 by being fitted in the first locking groove 45a. The in-cylinder magnet 43 accumulates urging force by being pressed and locked against the magnetic repulsive force generated between the opposing magnet 46. When the stopper 51 rotates in the direction of the arrow, the locking projection 52 moves to a substantially right angle portion where the first locking groove 45a and the first release groove 45b are connected (FIG. 4B). . The in-cylinder magnet 43 thus released from the lock presses the gasket 42 toward the cylinder tip 31 by the accumulated bias. The locking projection 52 slides on the first release groove 45b, moves to a substantially right angle portion where the second locking groove 45c is connected, and comes into contact with the locking groove 45c (FIG. 4C). )). Thereby, the in-cylinder magnet 43 is locked again. Half of the amount of the chemical solution 41 initially contained in the cylinder 30 is discharged.
 図4(c)で、ストッパ51により係止されている筒内磁石43は、図4(a)に比較して対向磁石46から離れているが、それら磁石が有する強力な磁力によって、筒内磁石43は、未だ磁性斥力による付勢を溜めている。ストッパ51を、図4(c)に示す矢印の方向へ回動させると、係止突起52は、第2の係止溝45cと第2の解除溝45dとが連結している略直角部に移動する(図4(d))。係止突起52は、第2の解除溝45bを滑り、筒内ホルダ44の基端を経て、嵌合部45に嵌合しなくなる。ガスケット42が筒内磁石43によって押圧されて摺動し、筒30の先端部に到達することによって、薬液41の排出は、完了する(図4(e))。 In FIG. 4C, the in-cylinder magnet 43 locked by the stopper 51 is separated from the opposing magnet 46 as compared with FIG. The magnet 43 is still accumulating bias due to magnetic repulsion. When the stopper 51 is rotated in the direction of the arrow shown in FIG. 4 (c), the locking projection 52 is positioned at a substantially right angle portion where the second locking groove 45c and the second release groove 45d are connected. Move (FIG. 4D). The locking projection 52 slides in the second release groove 45 b and does not fit into the fitting portion 45 through the proximal end of the in-cylinder holder 44. When the gasket 42 is pressed and slid by the in-cylinder magnet 43 and reaches the tip of the cylinder 30, the discharge of the chemical liquid 41 is completed (FIG. 4 (e)).
 このようにシリンジ10は、嵌合部45が、係止溝及び解除溝を複数有するものであると、ストッパ51を複数回動させることによって、薬液41を段階的に排出することができる。そのため、ストッパ51を1回回動させたときに摺動するガスケット42が、排出する薬液41の量を、1回当たりの用量とすることができる。その結果、数回分の用量の薬液41を予め筒30に収容しておき、目盛り等で排出量を確認することなく、1回の用量毎に排出して注射することができる。 Thus, the syringe 10 can discharge | release the chemical | medical solution 41 in steps by rotating the stopper 51 in multiple numbers, when the fitting part 45 has multiple locking grooves and cancellation | release grooves. Therefore, the gasket 42 that slides when the stopper 51 is rotated once can set the amount of the chemical solution 41 to be discharged to a dose per time. As a result, several doses of the drug solution 41 can be stored in the cylinder 30 in advance, and can be discharged and injected for each dose without confirming the discharge amount with a scale or the like.
 図5にシリンジ10の別な実施形態を示す。図5(a)は、シリンジ10の製造途中を示す斜視図である。ストッパ51は、アーチ形をなしており、その内周面で係止突起52と支持突起53とが突き出しているものである。それら突起52・53は、筒30に開いた貫通孔33と窪んだ凹部32bに対応してストッパ51から突き出している。係止突起52は、貫通孔33を経て嵌合部45に嵌まって筒内ホルダ44を係止している。支持突起53は、胴部32の外側壁の一部で窪んだ凹部32bに嵌っている。ストッパ51は、係止突起52が外れたときでも、支持突起53によって抜け落ちないように支えられる。ストッパ51の係止突起52側の一端は、アーチ形の湾曲から反り返った押圧フック54に繋がっている。押圧フック54の表面に、滑り止めのリブが設けられている。ストッパ51は、柔軟性を有する材料で成型されているので、多少撓ませても元の形状に復元できる。 FIG. 5 shows another embodiment of the syringe 10. FIG. 5A is a perspective view showing the manufacturing process of the syringe 10. The stopper 51 has an arch shape, and the locking projection 52 and the support projection 53 protrude from the inner peripheral surface thereof. The protrusions 52 and 53 protrude from the stopper 51 in correspondence with the through hole 33 opened in the cylinder 30 and the recessed portion 32b that is recessed. The locking projection 52 is fitted into the fitting portion 45 through the through hole 33 to lock the in-cylinder holder 44. The support protrusion 53 is fitted into a recessed portion 32 b that is recessed in a part of the outer wall of the body portion 32. The stopper 51 is supported by the support protrusion 53 so that it does not fall off even when the locking protrusion 52 is removed. One end of the stopper 51 on the side of the locking projection 52 is connected to a pressing hook 54 that has warped from an arch-shaped curve. Anti-slip ribs are provided on the surface of the pressing hook 54. Since the stopper 51 is formed of a flexible material, it can be restored to its original shape even if it is slightly bent.
 ストッパ51は、薬液41、ガスケット42及び筒内ホルダ44が筒30に挿入されてから取り付けられる。まず支持突起53を凹部32bに嵌める。この嵌め合わせを支点に、ストッパ51を広げて撓ませながら、係止突起52を嵌合部45に嵌める。筒内磁石43は、ストッパ51によって係止される。次いで対向磁石46を埋め込んだ固定ホルダ47を、筒内磁石43とN極同士を対向させつつ、開口34に嵌めて接着又は熱溶着により固定する。筒内磁石43は、対向磁石46との間に生じた磁性斥力で付勢されており、ストッパ51による係止によって、その付勢を溜めている。 The stopper 51 is attached after the chemical solution 41, the gasket 42 and the in-cylinder holder 44 are inserted into the cylinder 30. First, the support protrusion 53 is fitted into the recess 32b. With this fitting as a fulcrum, the locking projection 52 is fitted into the fitting portion 45 while the stopper 51 is expanded and bent. The in-cylinder magnet 43 is locked by the stopper 51. Next, the fixing holder 47 in which the counter magnet 46 is embedded is fitted into the opening 34 and fixed by adhesion or heat welding, with the in-cylinder magnet 43 and the N poles facing each other. The in-cylinder magnet 43 is urged by a magnetic repulsion generated between the counter magnet 46 and the urging force is accumulated by the locking by the stopper 51.
 例えば、薬液41を自己注射する際、患者は、注射針22を皮膚に穿刺した後、図5(b)に示すように、押圧フック54を、矢印の方向に押圧する。支持突起53と凹部32bとの嵌め合わせ箇所を支点に、ストッパ51が撓むことにより、係止突起52は、嵌合部45から外れる。それにより筒内磁石43は、係止が解除され、溜められた付勢でガスケット42を押圧する。図5(c)に示すように、ストッパ51は、それの柔軟性によって、元の形状に戻る。薬液41は、筒内磁石43の付勢で摺動するガスケット42によって、排出される。 For example, when self-injecting the drug solution 41, the patient punctures the skin with the injection needle 22, and then presses the pressing hook 54 in the direction of the arrow as shown in FIG. The locking projection 52 is detached from the fitting portion 45 when the stopper 51 is bent with the fitting portion of the support projection 53 and the recess 32b as a fulcrum. As a result, the in-cylinder magnet 43 is unlocked and presses the gasket 42 with the accumulated bias. As shown in FIG. 5C, the stopper 51 returns to its original shape due to its flexibility. The chemical liquid 41 is discharged by the gasket 42 that slides with the bias of the in-cylinder magnet 43.
 なお、凹部32bに代えて貫通孔33とし、かつ支持突起53に代えて係止突起52として、さらに対称な二つの嵌合部45を筒内ホルダ44に設けることにより、複数箇所で筒内ホルダ44ごと筒内磁石43を係止してもよい。両係止突起52と嵌合部45とが複数で嵌め合わされていることによって、より確実に筒内磁石43を係止することができる。 The cylindrical holder 44 is provided with two symmetrical fitting portions 45 as the through holes 33 instead of the recesses 32b and as the locking projections 52 instead of the support projections 53, so that the in-cylinder holders are provided at a plurality of locations. The in-cylinder magnet 43 may be locked together with 44. The in-cylinder magnet 43 can be more reliably locked by fitting the locking protrusions 52 and the fitting portions 45 in a plurality.
 図6に、シリンジ10の別な実施形態を示す。ストッパ51は、引抜フック56と、これの外周で繋がった係止ピン55とを有するものである。引抜フック56は、指を引っ掛けて引っ張り易いように、リング形状をなしている。筒30の側壁で、貫通孔33が対称に2つ開けられている。嵌合部45は、筒内ホルダ44を貫通した穴である。係止ピン55は、一方の貫通孔33を経て嵌合部45を貫いて嵌合し、他方の貫通孔33を経て、その先端を筒30外に突き出している。これにより、対向磁石46との間で生じた磁性斥力で付勢された筒内磁石43は、係止されてこの付勢を溜めている。係止ピン55の先端は、わずかに曲がっている。この曲がった先端は、引抜フック56へ不意に矢印方向の力が掛かった場合、嵌合部45に引っ掛ることによって、係止ピン55の不意な引抜を防止している。 FIG. 6 shows another embodiment of the syringe 10. The stopper 51 has a pull-out hook 56 and a locking pin 55 connected on the outer periphery thereof. The pull-out hook 56 has a ring shape so that it can be easily pulled by hooking a finger. Two through holes 33 are formed symmetrically on the side wall of the cylinder 30. The fitting portion 45 is a hole that penetrates the in-cylinder holder 44. The locking pin 55 is fitted through the fitting portion 45 through the one through hole 33, and the tip of the locking pin 55 projects out of the cylinder 30 through the other through hole 33. As a result, the in-cylinder magnet 43 urged by the magnetic repulsion generated between the counter magnet 46 is locked and accumulated. The tip of the locking pin 55 is slightly bent. When the force in the direction of the arrow is unexpectedly applied to the pulling hook 56, the bent tip prevents the locking pin 55 from being pulled out unexpectedly by being caught by the fitting portion 45.
 薬液41の排出の際、矢印方向で引抜フック56が引っ張られると、係止ピン55の先端が撓み嵌合部45へ引き込まれ、遂にはストッパ51が抜けて外れる。それにより、筒内磁石43は、係止が解除されて、ガスケット42を押圧し、摺動させる。薬液41が筒先31を経て注射針22から排出される。なお、引抜フック56は、数本の指が掛けられるように、その内径を大きく形成してもよいし、鉤形状に形成してもよい。 When the extraction hook 56 is pulled in the direction of the arrow during the discharge of the chemical solution 41, the tip of the locking pin 55 is bent and pulled into the fitting portion 45, and finally the stopper 51 comes off and comes off. As a result, the in-cylinder magnet 43 is unlocked, and presses and slides the gasket 42. The drug solution 41 is discharged from the injection needle 22 through the tube tip 31. Note that the pull-out hook 56 may be formed to have a large inner diameter or a hook shape so that several fingers can be hooked.
 図5及び図6に示すように、ストッパ51が、押圧フック54や引抜フック56を有していると、これを押したり、引っ張ったりするだけで薬液41を排出し、注射することができる。そのため、リウマチ患者のように、手の動きが不自由であったり、握力が弱かったりする患者や高齢者であっても、家族等の補助を要さず、自ら容易に注射することができるので、患者の自己注射時の負担を軽減することができる。 As shown in FIGS. 5 and 6, if the stopper 51 has a pressing hook 54 and a pulling hook 56, the drug solution 41 can be discharged and injected simply by pushing or pulling the stopper. Therefore, even patients with rheumatism, such as patients with hand movement difficulties or weak grip, and elderly people can easily inject themselves without the assistance of their family members. The burden on the patient during self-injection can be reduced.
 シリンジ10の別な実施形態の斜視図及び模式斜視図を、図7に示す。図7(a)に示すように、シリンジ10は、薬液41を収容した筒30と、円筒形状のストッパ51とを有するものである。筒30にガスケット42と、筒内磁石43が埋め込まれた筒内ホルダ44とが挿入されている。ストッパ51に、環形状をなした対向磁石46が、ストッパ51と同軸で埋め込まれている。筒内磁石43及び対向磁石46は、ともに夫々の周方向で4極に着磁されているラジアル異方性磁石である。筒30の側壁で、鍔部32cが突き出している。 FIG. 7 shows a perspective view and a schematic perspective view of another embodiment of the syringe 10. As shown to Fig.7 (a), the syringe 10 has the cylinder 30 which accommodated the chemical | medical solution 41, and the cylindrical stopper 51. As shown in FIG. A gasket 42 and an in-cylinder holder 44 in which an in-cylinder magnet 43 is embedded are inserted into the cylinder 30. A counter magnet 46 having an annular shape is embedded in the stopper 51 coaxially with the stopper 51. Both the in-cylinder magnet 43 and the counter magnet 46 are radial anisotropic magnets magnetized to four poles in the respective circumferential directions. On the side wall of the cylinder 30, the collar portion 32c protrudes.
 ストッパ51は、筒30の基端から筒30に挿通され、筒30の先端部側の端面を鍔部32cに当接させている。ストッパ51は、筒30と同軸で回動できる。ストッパ51の外周は、指で摘んだり挟んだりして回動させ易いように中程で窪んでいる。 The stopper 51 is inserted into the cylinder 30 from the base end of the cylinder 30, and the end surface of the cylinder 30 on the distal end side is brought into contact with the flange portion 32c. The stopper 51 can rotate coaxially with the cylinder 30. The outer periphery of the stopper 51 is recessed in the middle so that it can be easily picked or pinched with fingers and rotated.
 開口34は、蓋57が嵌められて塞がれている。蓋57は、開口34に嵌るリング部57aの基端が、これより大径の押え部57bに繋がった形状をなしている。蓋57の中央に空気孔57cが開いている。この空気孔57cは、ガスケット42が筒先31へ向かって摺動した際に、ガスケット42よりも基端側の筒30内へ空気を導入し、ガスケット42の摺動をスムーズにするためのものである。押え部57bは、筒30の側壁よりも僅かに突き出て、ストッパ51に当接している。ストッパ51は、鍔部32cと押え部57bとに挟まれていることによって、筒30から抜け落ちない。 The opening 34 is closed with a lid 57 fitted. The lid 57 has a shape in which the base end of the ring portion 57a fitted in the opening 34 is connected to the presser portion 57b having a larger diameter. An air hole 57 c is opened at the center of the lid 57. The air hole 57c is for introducing air into the cylinder 30 on the base end side of the gasket 42 when the gasket 42 slides toward the cylinder tip 31, so that the gasket 42 slides smoothly. is there. The presser portion 57 b protrudes slightly from the side wall of the cylinder 30 and is in contact with the stopper 51. The stopper 51 does not fall out of the cylinder 30 by being sandwiched between the collar portion 32c and the pressing portion 57b.
 筒内磁石43は、筒内ホルダ44の側面で窪んだ掛止部44aと筒30の内壁で出っ張った回止片32aとが引っ掛け合っていることによって、筒30内で回動が制限されている。 The in-cylinder magnet 43 is restricted in rotation within the cylinder 30 by the hooking portion 44 a that is recessed on the side surface of the in-cylinder holder 44 and the locking piece 32 a that protrudes from the inner wall of the cylinder 30 being engaged with each other. Yes.
 図7(b)及び(c)は、筒内磁石43及び対向磁石46の磁極の位置を示す模式斜視図である。図7(b)に示すように、対向磁石46は、筒内磁石43と異磁極同士を対向させつつ、筒内磁石43を取り囲んでいる。回止片32aと掛止部44aとの引っ掛け合わせにより筒内磁石43の回動が防止されていることと、この筒内磁石43との間に生じた磁性斥力により引き付けられていることとによって、対向磁石46は、回動しないように係止されている。筒内磁石43は、対向磁石46よりも幾分筒先側へ突き出ている。 7 (b) and 7 (c) are schematic perspective views showing the positions of the magnetic poles of the in-cylinder magnet 43 and the counter magnet 46. FIG. As shown in FIG. 7B, the counter magnet 46 surrounds the in-cylinder magnet 43 while the in-cylinder magnet 43 and the different magnetic poles are opposed to each other. The rotation of the in-cylinder magnet 43 is prevented by the hooking of the stop piece 32a and the hooking portion 44a, and the magnetic repulsive force generated between the in-cylinder magnet 43 is attracted. The counter magnet 46 is locked so as not to rotate. The in-cylinder magnet 43 protrudes somewhat toward the cylinder tip side than the counter magnet 46.
 ストッパ51の回動により、対向磁石46の係止が解除される。図7(c)に示すように、対向磁石46は、筒内磁石43と同磁極同士で対向する。筒内磁石43は、対向磁石46との間に磁性斥力を生じ、それにより付勢されてガスケット42を押圧する。薬液41は、押圧されたガスケットの摺動により、筒先31を経て注射針22から排出される。 When the stopper 51 is rotated, the opposing magnet 46 is unlocked. As shown in FIG. 7C, the counter magnet 46 is opposed to the cylinder magnet 43 with the same magnetic poles. The in-cylinder magnet 43 generates a magnetic repulsive force with the counter magnet 46 and is biased thereby to press the gasket 42. The drug solution 41 is discharged from the injection needle 22 through the tube tip 31 by sliding of the pressed gasket.
 このようにシリンジ10は、ストッパ51を指で挟み、わずかな力で手首を動かして回すだけで、薬液41を排出できるものである。そのため、指先で細かな操作を行うことが困難な患者でも容易に注射することができる。また、対向磁石46が埋め込まれた固定ホルダ47を筒30に固定するのに、接着剤を用いる必要がないので、薬液41を汚染する恐れがなく、シリンジ10は、衛生的である。 In this way, the syringe 10 can discharge the liquid medicine 41 simply by pinching the stopper 51 with a finger and moving the wrist with a slight force. Therefore, even a patient who is difficult to perform a fine operation with a fingertip can be easily injected. Further, since it is not necessary to use an adhesive to fix the fixing holder 47 in which the opposing magnet 46 is embedded to the cylinder 30, there is no possibility of contaminating the chemical liquid 41, and the syringe 10 is hygienic.
 なお、図7に筒内磁石43及び対向磁石46が、それらの周方向に4極で着磁されている例を示したが、それら磁石は、少なくとも2極で着磁されていればよく、6極でもそれ以上であってもよい。 FIG. 7 shows an example in which the in-cylinder magnet 43 and the counter magnet 46 are magnetized with four poles in their circumferential direction. However, these magnets only need to be magnetized with at least two poles, It may be 6 poles or more.
 回止片32aと掛止部44aとにより、又は爪47aにより、ガスケット42の回動を抑制する例を示したが、これらは、ガスケット42と筒30の内壁との摩擦によりガスケット42の回動を生じない場合には、設けなくてもよい。 Although the example which suppresses rotation of the gasket 42 by the rotation piece 32a and the latching | locking part 44a or the nail | claw 47a was shown, these are rotation of the gasket 42 by friction with the gasket 42 and the inner wall of the cylinder 30. If it does not occur, it may not be provided.
 筒30内に収容される薬液41は、例えばブドウ糖等の糖液注射液、塩化ナトリウムや乳酸カリウム等の電解質補正用注射液、抗不整脈剤、抗痙攣剤、インスリン製剤、タンパク製剤、抗体薬、抗リウマチ薬、気管支拡張剤、造影剤、ステロイド剤、タンパク質分解酵素阻害剤、脂肪乳剤、抗生物質、抗がん剤、ヘパリンカルシウム、麻酔薬及び抗体薬等が挙げられる。また、インフルエンザ、破傷風、肺炎球菌、ポリオ、日本脳炎、風疹、麻疹、黄熱、ヒブ、肝炎、水痘、狂犬病、ロタウィルス、おたふくかぜ、子宮頸がん予防、MQ、DT及びDPT等のワクチンのような生物医薬が挙げられる。 The drug solution 41 accommodated in the cylinder 30 is, for example, a sugar solution injection solution such as glucose, an electrolyte correction injection solution such as sodium chloride or potassium lactate, an antiarrhythmic agent, an anticonvulsant, an insulin preparation, a protein preparation, an antibody drug, Antirheumatic drugs, bronchodilators, contrast agents, steroids, proteolytic enzyme inhibitors, fat emulsions, antibiotics, anticancer agents, heparin calcium, anesthetics, antibody drugs and the like can be mentioned. Influenza, tetanus, pneumococci, polio, Japanese encephalitis, rubella, measles, yellow fever, hives, hepatitis, chickenpox, rabies, rotavirus, mumps, cervical cancer prevention, MQ, DT and DPT vaccines Such biopharmaceuticals.
 筒30の内径は、5~30mmが好ましい。内径がこの範囲よりも小さいと、筒30の成型が困難である。またこの範囲より大きいと、ガスケット42を摺動させる力が大きくなり、強力な磁性斥力が必要になるので、筒内磁石43及び対向磁石46を大きくしなければならず、シリンジ10が重くなって携帯性が損なわれてしまう。 The inner diameter of the cylinder 30 is preferably 5 to 30 mm. If the inner diameter is smaller than this range, it is difficult to mold the cylinder 30. If it is larger than this range, the force for sliding the gasket 42 becomes large and a strong magnetic repulsive force is required. Therefore, the in-cylinder magnet 43 and the counter magnet 46 must be enlarged, and the syringe 10 becomes heavy. Portability is impaired.
 シリンジ10は、エチレンオキサイドガス、γ線、電子線、及びオートクレーブでの高圧蒸気の何れかによる滅菌処理が行われていてもよい。滅菌の方法や手順は、筒30の材質、注射する薬液41の種類・安定性、シリンジ10の大きさ・形状等に応じて適宜選択される。 The syringe 10 may be sterilized by any of ethylene oxide gas, γ rays, electron beams, and high pressure steam in an autoclave. The sterilization method and procedure are appropriately selected according to the material of the cylinder 30, the type and stability of the liquid medicine 41 to be injected, the size and shape of the syringe 10, and the like.
 筒30、筒内ホルダ44、固定ホルダ47、ストッパ51、押圧フック54、係止ピン55、引抜フック56、及び蓋57の材料は、耐薬品性、ガス・菌バリア性、生体への安全性等の観点から選択される。例えばポリエチレン、ポリプロピレン、環状ポリオレフィンのようなポリオレフィン樹脂;ポリスチレン;ポリカーボネート;ポリエチレンテレフタレートのようなポリエステル;ポリアミドが用いられる。特に滅菌処理をオートクレーブで行う場合、これらの材料としては、耐熱性の高い樹脂、例えばポリプロピレン又はポリカーボネートを用いることが好ましい。また、筒30の材料としては、筒30内に収容された薬液41を外側から視認できるように高い透明度を有し、薬液41との相互作用が少なく、かつ薬液41の投与時に強く握られたり押されたりしても曲がらずかつ潰れない剛性をもつ樹脂である環状オレフィンホモポリマー又は環状オレフィンコポリマーを用いることが好ましい。その成形法は、射出成形法、ブロー成形法、熱成形法等を用いることができ、なかでも射出成形法が好ましい。 The material of the cylinder 30, the in-cylinder holder 44, the fixing holder 47, the stopper 51, the pressing hook 54, the locking pin 55, the pulling hook 56, and the lid 57 is chemical resistance, gas / bacteria barrier property, and safety to living bodies. Are selected from the viewpoint of For example, polyolefin resin such as polyethylene, polypropylene and cyclic polyolefin; polystyrene; polycarbonate; polyester such as polyethylene terephthalate; In particular, when sterilization is performed in an autoclave, it is preferable to use a resin having high heat resistance, such as polypropylene or polycarbonate, as these materials. Further, as the material of the cylinder 30, it has a high transparency so that the drug solution 41 accommodated in the cylinder 30 can be visually recognized from the outside, has little interaction with the drug solution 41, and is strongly gripped when the drug solution 41 is administered. It is preferable to use a cyclic olefin homopolymer or a cyclic olefin copolymer, which is a resin that does not bend and does not collapse even when pressed. As the molding method, an injection molding method, a blow molding method, a thermoforming method, or the like can be used, and among these, the injection molding method is preferable.
 キャップ21及びガスケット42の材料は、上記と同様の観点から選択される。例えばオレフィン系、ポリウレタン系、ポリエステル系、ポリアミド系又はスチレン系の熱可塑性エラストマーや、天然ゴム、イソプレンゴム、ブタジエンゴム、スチレン-ブタジエンゴム、シリコーンゴムのようなゴム材料が用いられる。 The materials of the cap 21 and the gasket 42 are selected from the same viewpoint as described above. For example, rubber materials such as olefin-based, polyurethane-based, polyester-based, polyamide-based or styrene-based thermoplastic elastomers, natural rubber, isoprene rubber, butadiene rubber, styrene-butadiene rubber, and silicone rubber are used.
 本発明のシリンジは、患者へ薬液を注射するために用いられる。 The syringe of the present invention is used for injecting a drug solution into a patient.
 本発明の薬液排出方法は、自己注射や医療機関での注射の際に用いられる。 The chemical solution discharging method of the present invention is used for self-injection or injection at a medical institution.
10:シリンジ、 21:キャップ、 22:注射針、 30:筒、 31:筒先、 32:胴部、 32a:回止片、 32b:凹部、 32c:鍔部、 33:貫通孔、 34:開口、 41:薬液、 42:ガスケット、 42a:穴、 43:筒内磁石、 44:筒内ホルダ、 44a:掛止部、 44b:鉤部、 45:嵌合部、 45a,45c:係止溝、 45b,45d:解除溝、 46:対向磁石、 47:固定ホルダ、 47a:爪、 51:ストッパ、52:係止突起、 53:支持突起、 54:押圧フック、 55:係止ピン、 56:引抜フック、 57:蓋、 57a:リング部、 57b:押え部、 57c:空気孔 10: Syringe, 21: Cap, 22: Injection needle, 30: Tube, 31: Tube tip, 32: Body, 32a: Rotating piece, 32b: Recess, 32c: Gutter, 33: Through hole, 34: Opening, 41: chemical solution, 42: gasket, 42a: hole, 43: in-cylinder magnet, 44: in-cylinder holder, 44a: latching part, 44b: collar part, 45: fitting part, 45a, 45c: locking groove, 45b , 45d: release groove, 46: counter magnet, 47: fixed holder, 47a: claw, 51: stopper, 52: locking protrusion, 53: support protrusion, 54: pressing hook, 55: locking pin, 56: pulling hook 57: lid, 57a: ring part, 57b: presser part, 57c: air hole

Claims (9)

  1.  先端部に筒先、及び基端部に開口が設けられた筒と、前記筒に挿入され、押圧により摺動するガスケットと、前記筒内で前記筒先及び前記ガスケットの間に収容され前記ガスケットの摺動により前記筒先から排出される薬液とを有するシリンジであって、
     前記筒に挿入されている筒内磁石と、
     前記筒に固定され又は前記筒を取り囲んでおり、前記筒内磁石と同磁極同士で対向させることによって生じる磁性斥力で、付勢を生じさせて前記先端部への前記ガスケットの前記摺動を誘発する対向磁石とを、
    備え、前記筒内磁石と前記対向磁石との少なくとも何れかが、前記筒に係止されており、その係止を解除するまで前記付勢を溜め、又はその係止を解除させてから前記付勢を生じさせて、前記押圧を開始させることを特徴とするシリンジ。
    A cylinder having a tube tip at the distal end and an opening at the base end, a gasket that is inserted into the cylinder and slides by pressing, and is accommodated in the cylinder between the tube tip and the gasket and slides on the gasket. A syringe having a liquid medicine discharged from the tube tip by movement,
    An in-cylinder magnet inserted into the cylinder;
    A magnetic repulsive force that is fixed to or surrounds the cylinder and is caused to face each other by the same magnetic pole as the in-cylinder magnet, and generates a bias to induce the sliding of the gasket to the tip portion. An opposing magnet to
    And at least one of the in-cylinder magnet and the counter magnet is locked to the cylinder, and the urging is accumulated until the locking is released, or the locking is released and then the attachment is performed. A syringe characterized by causing a force to start the pressing.
  2.  前記筒内磁石と、前記対向磁石とが、互いに同磁極同士で対向しつつ前記磁性斥力に反して押し付け合うことによって、前記付勢を生じさせており、ストッパが、前記筒内磁石を係止していることによって、前記付勢を溜めていることを特徴とする請求項1に記載のシリンジ。 The in-cylinder magnet and the counter magnet are pressed against each other against the magnetic repulsive force while facing each other with the same magnetic poles, and the bias is generated, and a stopper locks the in-cylinder magnet. The syringe according to claim 1, wherein the urging force is accumulated.
  3.  側面に嵌合部を有する筒内ホルダに前記筒内磁石が埋め込まれており、前記ストッパが前記嵌合部に嵌合していることによって、前記筒内磁石を係止していることを特徴とする請求項2に記載のシリンジ。 The in-cylinder magnet is embedded in an in-cylinder holder having a fitting portion on a side surface, and the stopper is engaged with the fitting portion, thereby locking the in-cylinder magnet. The syringe according to claim 2.
  4.  前記嵌合部が、前記筒内ホルダの周方向に窪み前記筒内磁石ごと前記筒内ホルダを係止させている溝と、前記筒内ホルダの中心軸方向に窪み前記係止を解除する溝とを、連結させているものであることを特徴とする請求項3に記載のシリンジ。 A groove in which the fitting portion is recessed in the circumferential direction of the in-cylinder holder and the in-cylinder magnet is locked with the in-cylinder magnet, and a groove is recessed in the central axis direction of the in-cylinder holder and the locking is released. The syringe according to claim 3, which is connected to each other.
  5.  前記ストッパと前記嵌合部との嵌合を前記筒の外側から外して、前記係止を解除するフックが、前記ストッパに設けられていることを特徴とする請求項3に記載のシリンジ。 4. The syringe according to claim 3, wherein the stopper is provided with a hook for releasing the engagement by removing the fitting of the stopper and the fitting portion from the outside of the cylinder.
  6.  前記筒内磁石と、前記筒内磁石ごと前記筒を取り囲んでいる環状の前記対向磁石とが、夫々の側面の周方向で着磁されて、異磁極同士の対向で磁性引力を生じつつ、ストッパが、前記対向磁石を回動不能に係止していることにより、前記係止を解除させてから前記付勢を生じさせることを特徴とする請求項1に記載のシリンジ。 The in-cylinder magnet and the annular counter magnet surrounding the cylinder together with the in-cylinder magnet are magnetized in the circumferential direction of the respective side surfaces, and a magnetic attractive force is generated by opposing the different magnetic poles, and a stopper The syringe according to claim 1, wherein the biasing is generated after the locking is released by locking the counter magnet in a non-rotatable manner.
  7.  前記筒内磁石及び前記対向磁石が、ラジアル異方性磁石であることを特徴とする請求項6に記載のシリンジ。 The syringe according to claim 6, wherein the in-cylinder magnet and the counter magnet are radial anisotropic magnets.
  8.  前記筒内磁石が、筒内ホルダに埋め込まれていることを特徴とする請求項7に記載のシリンジ。 The syringe according to claim 7, wherein the in-cylinder magnet is embedded in an in-cylinder holder.
  9.  先端部に筒先、及び基端部に開口が設けられた筒と、前記筒に挿入され押圧により摺動するガスケットと、前記筒内で前記筒先及び前記ガスケットの間に収容され前記ガスケットの摺動で前記筒先から排出される薬液とを有するシリンジから、前記薬液を排出する方法であって、
     前記筒に筒内磁石を挿入する工程、
     前記筒内磁石へ同磁極同士で対向させる対向磁石を、それらの磁性斥力により付勢させ又は付勢できるように前記筒に固定し又は前記筒に取り囲ませる工程、
     前記筒内磁石と前記対向磁石との少なくとも何れかを係止し、その係止を解除するまで前記付勢を溜め、又はその係止を解除させてから前記付勢を生じさせる工程、
     前記係止の解除に応じ、前記付勢によって、前記筒内磁石で前記ガスケットに前記先端部への前記摺動を誘発させて、前記押圧を生じさせて前記薬液を排出する工程
    を有することを特徴とする薬液排出方法。
    A cylinder with a tube tip at the tip and an opening at the base end, a gasket that is inserted into the cylinder and slides by pressing, and a sliding of the gasket that is accommodated between the cylinder tip and the gasket in the cylinder And a method for discharging the chemical solution from a syringe having the chemical solution discharged from the tube tip,
    Inserting an in-cylinder magnet into the cylinder;
    A step of fixing the opposing magnets facing the in-cylinder magnets with the same magnetic poles to be energized or energized by their magnetic repulsive force or surrounding the cylinders;
    Locking at least one of the in-cylinder magnet and the counter magnet, storing the bias until the lock is released, or generating the bias after releasing the lock;
    In response to the release of the locking, the biasing has a step of inducing the sliding of the gasket to the tip by the in-cylinder magnet to cause the pressing to discharge the chemical solution. A method for discharging a chemical solution.
PCT/JP2013/059911 2013-04-01 2013-04-01 Syringe WO2014162439A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2013/059911 WO2014162439A1 (en) 2013-04-01 2013-04-01 Syringe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2013/059911 WO2014162439A1 (en) 2013-04-01 2013-04-01 Syringe

Publications (1)

Publication Number Publication Date
WO2014162439A1 true WO2014162439A1 (en) 2014-10-09

Family

ID=51657772

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/059911 WO2014162439A1 (en) 2013-04-01 2013-04-01 Syringe

Country Status (1)

Country Link
WO (1) WO2014162439A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107714103A (en) * 2017-10-27 2018-02-23 北京市春立正达医疗器械股份有限公司 Syringe
CN107920882A (en) * 2015-08-19 2018-04-17 高露洁-棕榄公司 Multi-chemistry distributor
CN108392417A (en) * 2018-04-08 2018-08-14 中国人民解放军总医院 Hand-held dispensation apparatus
CN112048845A (en) * 2020-09-08 2020-12-08 湖南奔立尔工贸实业有限公司 Protection device at needle head
CN117414298A (en) * 2023-12-18 2024-01-19 江苏大同盟制药有限公司 Injection container for rapid liquid preparation of small-volume injection

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508233A (en) * 2001-10-26 2005-03-31 マサチューセッツ インスティテュート オブ テクノロジー Needle-free injection device
US20060173409A1 (en) * 2004-12-28 2006-08-03 Chang-Ming Yang Safety syring
JP2009502273A (en) * 2005-07-27 2009-01-29 ノボ・ノルデイスク・エー/エス Dosing mechanism of an injection device that limits the setting of the dose corresponding to the remaining amount of the drug
JP2012513855A (en) * 2008-12-31 2012-06-21 オウエン マンフォード リミティド Self-injector

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508233A (en) * 2001-10-26 2005-03-31 マサチューセッツ インスティテュート オブ テクノロジー Needle-free injection device
US20060173409A1 (en) * 2004-12-28 2006-08-03 Chang-Ming Yang Safety syring
JP2009502273A (en) * 2005-07-27 2009-01-29 ノボ・ノルデイスク・エー/エス Dosing mechanism of an injection device that limits the setting of the dose corresponding to the remaining amount of the drug
JP2012513855A (en) * 2008-12-31 2012-06-21 オウエン マンフォード リミティド Self-injector

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107920882A (en) * 2015-08-19 2018-04-17 高露洁-棕榄公司 Multi-chemistry distributor
CN107714103A (en) * 2017-10-27 2018-02-23 北京市春立正达医疗器械股份有限公司 Syringe
CN108392417A (en) * 2018-04-08 2018-08-14 中国人民解放军总医院 Hand-held dispensation apparatus
CN108392417B (en) * 2018-04-08 2023-09-01 中国人民解放军总医院 Hand-held dispensing device
CN112048845A (en) * 2020-09-08 2020-12-08 湖南奔立尔工贸实业有限公司 Protection device at needle head
CN117414298A (en) * 2023-12-18 2024-01-19 江苏大同盟制药有限公司 Injection container for rapid liquid preparation of small-volume injection
CN117414298B (en) * 2023-12-18 2024-03-08 江苏大同盟制药有限公司 Injection container for rapid liquid preparation of small-volume injection

Similar Documents

Publication Publication Date Title
AU2003223720B2 (en) Safety injectors
US7670314B2 (en) Injection device for administering a vaccine
US5713871A (en) Protective sleeve for hypodermic needle
KR100317900B1 (en) Drug injection device and drug injection method using it
JP6499158B2 (en) Prefilled syringe
JP6511442B2 (en) Injection device
WO2014162439A1 (en) Syringe
JP6738937B2 (en) Syringe
US20080154212A1 (en) Syringe with retractable needle support
WO2014162466A1 (en) Syringe
WO2017170635A1 (en) Medicine administering apparatus, method of using medicine administering apparatus, and method for manufacturing medicine administering apparatus
JP2018520776A (en) Single use delivery device with safety features
JP2013180130A (en) Syringe
JPWO2014136652A1 (en) Liquid dosing device
US20180318510A1 (en) Injection device
RU2758559C1 (en) Protection and filling system for syringes with retractable needle
JPH0323248Y2 (en)
KR20220138210A (en) Holder For Liquid Medicine Cartridge
GB2522292A (en) Fluid transfer devices

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13880717

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13880717

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP